<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:40:57Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:3131273" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:3131273</identifier><datestamp>2011-07-12</datestamp><setSpec>plosgen</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">PLoS Genet</journal-id>
      <journal-id journal-id-type="iso-abbrev">PLoS Genet</journal-id>
      <journal-id journal-id-type="publisher-id">plos</journal-id>
      <journal-id journal-id-type="pmc">plosgen</journal-id>
      <journal-title-group>
        <journal-title>PLoS Genetics</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1553-7390</issn>
      <issn pub-type="epub">1553-7404</issn>
      <publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC3131273</article-id>
      <article-id pub-id-type="pmcid">PMC3131273</article-id>
      <article-id pub-id-type="pmc-uid">3131273</article-id>
      <article-id pub-id-type="pmid">21750680</article-id>
      <article-id pub-id-type="pmid">21750680</article-id>
      <article-id pub-id-type="publisher-id">PGENETICS-D-10-00626</article-id>
      <article-id pub-id-type="doi">10.1371/journal.pgen.1002114</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Biology</subject>
          <subj-group>
            <subject>Genetics</subject>
            <subj-group>
              <subject>Human Genetics</subject>
              <subj-group>
                <subject>Autosomal Recessive</subject>
              </subj-group>
            </subj-group>
            <subj-group>
              <subject>Animal Genetics</subject>
              <subject>Gene Expression</subject>
              <subject>Genetics of Disease</subject>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Medicine</subject>
          <subj-group>
            <subject>Clinical Genetics</subject>
            <subj-group>
              <subject>Autosomal Recessive</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Loss of the BMP Antagonist, SMOC-1, Causes Ophthalmo-Acromelic (Waardenburg Anophthalmia) Syndrome in Humans and Mice</article-title>
        <alt-title alt-title-type="running-head">SMOC1 Mutations Cause Ophthalmo-Acromelic Syndrome</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Rainger</surname>
            <given-names>Joe</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>van Beusekom</surname>
            <given-names>Ellen</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ramsay</surname>
            <given-names>Jacqueline K.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>McKie</surname>
            <given-names>Lisa</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Al-Gazali</surname>
            <given-names>Lihadh</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pallotta</surname>
            <given-names>Rosanna</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Saponari</surname>
            <given-names>Anita</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Branney</surname>
            <given-names>Peter</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fisher</surname>
            <given-names>Malcolm</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Morrison</surname>
            <given-names>Harris</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bicknell</surname>
            <given-names>Louise</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gautier</surname>
            <given-names>Philippe</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Perry</surname>
            <given-names>Paul</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sokhi</surname>
            <given-names>Kishan</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sexton</surname>
            <given-names>David</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bardakjian</surname>
            <given-names>Tanya M.</given-names>
          </name>
          <xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Schneider</surname>
            <given-names>Adele S.</given-names>
          </name>
          <xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Elcioglu</surname>
            <given-names>Nursel</given-names>
          </name>
          <xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ozkinay</surname>
            <given-names>Ferda</given-names>
          </name>
          <xref ref-type="aff" rid="aff8">
<sup>8</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Koenig</surname>
            <given-names>Rainer</given-names>
          </name>
          <xref ref-type="aff" rid="aff9">
<sup>9</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>MÃ©garbanÃ©</surname>
            <given-names>Andre</given-names>
          </name>
          <xref ref-type="aff" rid="aff10">
<sup>10</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Semerci</surname>
            <given-names>C. Nur</given-names>
          </name>
          <xref ref-type="aff" rid="aff11">
<sup>11</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Khan</surname>
            <given-names>Ayesha</given-names>
          </name>
          <xref ref-type="aff" rid="aff12">
<sup>12</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zafar</surname>
            <given-names>Saemah</given-names>
          </name>
          <xref ref-type="aff" rid="aff12">
<sup>12</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hennekam</surname>
            <given-names>Raoul</given-names>
          </name>
          <xref ref-type="aff" rid="aff13">
<sup>13</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sousa</surname>
            <given-names>SÃ©rgio B.</given-names>
          </name>
          <xref ref-type="aff" rid="aff14">
<sup>14</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ramos</surname>
            <given-names>Lina</given-names>
          </name>
          <xref ref-type="aff" rid="aff14">
<sup>14</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Garavelli</surname>
            <given-names>Livia</given-names>
          </name>
          <xref ref-type="aff" rid="aff15">
<sup>15</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Furga</surname>
            <given-names>Andrea Superti</given-names>
          </name>
          <xref ref-type="aff" rid="aff16">
<sup>16</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wischmeijer</surname>
            <given-names>Anita</given-names>
          </name>
          <xref ref-type="aff" rid="aff15">
<sup>15</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jackson</surname>
            <given-names>Ian J.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gillessen-Kaesbach</surname>
            <given-names>Gabriele</given-names>
          </name>
          <xref ref-type="aff" rid="aff17">
<sup>17</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Brunner</surname>
            <given-names>Han G.</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wieczorek</surname>
            <given-names>Dagmar</given-names>
          </name>
          <xref ref-type="aff" rid="aff18">
<sup>18</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>van Bokhoven</surname>
            <given-names>Hans</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
          <xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>FitzPatrick</surname>
            <given-names>David R.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
          <xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <label>1</label>
        <addr-line>Medical Research Council Human Genetics Unit, Institute of Genetics and Molecular Medicine, Western General Hospital, Edinburgh, United Kingdom</addr-line>
      </aff>
      <aff id="aff2">
        <label>2</label>
        <addr-line>Department of Human Genetics, Institute for Genetic and Metabolic Disorders and Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands</addr-line>
      </aff>
      <aff id="aff3">
        <label>3</label>
        <addr-line>Departments of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, United Arab Emirates</addr-line>
      </aff>
      <aff id="aff4">
        <label>4</label>
        <addr-line>Regional Service for Diagnosis, Prevention, and Care of Birth Defects, Department of Medicine and Aging Sciences, Section of Preventive and Social Pediatrics, G. D'Annunzio University, Chieti, Italy</addr-line>
      </aff>
      <aff id="aff5">
        <label>5</label>
        <addr-line>Department of Orthopaedics and Trauma, University of Edinburgh, Royal Infirmary of Edinburgh, Little France, Edinburgh, United Kingdom</addr-line>
      </aff>
      <aff id="aff6">
        <label>6</label>
        <addr-line>Division of Genetics, Department of Pediatrics, Albert Einstein Medical Center, Philadelphia, Pennsylvania, United States of America</addr-line>
      </aff>
      <aff id="aff7">
        <label>7</label>
        <addr-line>Department of Pediatric Genetics, Marmara University Hospital, Istanbul, Turkey</addr-line>
      </aff>
      <aff id="aff8">
        <label>8</label>
        <addr-line>Ege University, Medical Faculty, Department of Pediatrics, Izmir, Turkey</addr-line>
      </aff>
      <aff id="aff9">
        <label>9</label>
        <addr-line>Institut fÃ¼r Humangenetik der Johann Wolfgang Goethe UniversitÃ¤t, Frankfurt, Germany</addr-line>
      </aff>
      <aff id="aff10">
        <label>10</label>
        <addr-line>UnitÃ© de GÃ©nÃ©tique MÃ©dicale, FacultÃ© de MÃ©decine, UniversitÃ© Saint Joseph, Beirut, Lebanon</addr-line>
      </aff>
      <aff id="aff11">
        <label>11</label>
        <addr-line>Department of Medical Genetics, School of Medicine, Pamukkale University, Denizli, Turkey</addr-line>
      </aff>
      <aff id="aff12">
        <label>12</label>
        <addr-line>Al-Shifa Trust Eye Hospital, Rawalpindi, Pakistan</addr-line>
      </aff>
      <aff id="aff13">
        <label>13</label>
        <addr-line>Department of Pediatrics and Department of Translational Genetics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands</addr-line>
      </aff>
      <aff id="aff14">
        <label>14</label>
        <addr-line>ServiÃ§o GenÃ©tica MÃ©dica, Hospital PediÃ¡trico de Coimbra, Portugal</addr-line>
      </aff>
      <aff id="aff15">
        <label>15</label>
        <addr-line>Department of Clinical Genetics, S. Maria Nuova Hospital, Reggio Emilia, Italy</addr-line>
      </aff>
      <aff id="aff16">
        <label>16</label>
        <addr-line>Department of Pediatrics, University of Lausanne, Switzerland</addr-line>
      </aff>
      <aff id="aff17">
        <label>17</label>
        <addr-line>Institut fÃ¼r Humangenetik, UniversitÃ¤t zu LÃ¼beck, LÃ¼beck, Germany</addr-line>
      </aff>
      <aff id="aff18">
        <label>18</label>
        <addr-line>Institut fÃ¼r Humangenetik, UniversitÃ¤tsklinikum Essen, Essen, Germany</addr-line>
      </aff>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Wilkie</surname>
            <given-names>Andrew O. M.</given-names>
          </name>
          <role>Editor</role>
          <xref ref-type="aff" rid="edit1"/>
        </contrib>
      </contrib-group>
      <aff id="edit1">University of Oxford, United Kingdom</aff>
      <author-notes>
        <corresp id="cor1">* E-mail: <email>david.fitzpatrick@hgu.mrc.ac.uk</email> (DRF); <email>H.vanBokhoven@antrg.umcn.nl</email> (HvB)</corresp>
        <fn fn-type="con">
          <p>Conceived and designed the experiments: JR DW HGB HvB DRF. Performed the experiments: JR LA-G EvB JKR LM PB MF HM PG PP KS DS. Analyzed the data: JR EvB LB HvB DRF. Contributed reagents/materials/analysis tools: IJJ DW GGK LG ASF AW AK SZ NE RP AS TMB ASS LA-G HGB FO RK AM CNS RH LR SBdS. Wrote the paper: JR HvB DRF.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="collection">
        <month>7</month>
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>7</day>
        <month>7</month>
        <year>2011</year>
      </pub-date>
      <volume>7</volume>
      <issue>7</issue>
      <elocation-id>e1002114</elocation-id>
      <history>
        <date date-type="received">
          <day>29</day>
          <month>12</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>15</day>
          <month>4</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Rainger et al.</copyright-statement>
        <copyright-year>2011</copyright-year>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Ophthalmo-acromelic syndrome (OAS), also known as Waardenburg Anophthalmia syndrome, is defined by the combination of eye malformations, most commonly bilateral anophthalmia, with post-axial oligosyndactyly. Homozygosity mapping and subsequent targeted mutation analysis of a locus on 14q24.2 identified homozygous mutations in <italic>SMOC1</italic> (<italic>SPARC-related modular calcium binding 1</italic>) in eight unrelated families. Four of these mutations are nonsense, two frame-shift, and two missense. The missense mutations are both in the second Thyroglobulin Type-1 (Tg1) domain of the protein. The orthologous gene in the mouse, <italic>Smoc1</italic>, shows site- and stage-specific expression during eye, limb, craniofacial, and somite development. We also report a targeted pre-conditional gene-trap mutation of <italic>Smoc1</italic> (<italic>Smoc1<sup>tm1a</sup></italic>) that reduces mRNA to â¼10% of wild-type levels. This gene-trap results in highly penetrant hindlimb post-axial oligosyndactyly in homozygous mutant animals (<italic>Smoc1<sup>tm1a/tm1a</sup></italic>). Eye malformations, most commonly coloboma, and cleft palate occur in a significant proportion of <italic>Smoc1<sup>tm1a/tm1a</sup></italic> embryos and pups. Thus partial loss of Smoc-1 results in a convincing phenocopy of the human disease. SMOC-1 is one of the two mammalian paralogs of <italic>Drosophila</italic> Pentagone, an inhibitor of decapentaplegic. The orthologous gene in <italic>Xenopus laevis</italic>, <italic>Smoc-1</italic>, also functions as a Bone Morphogenic Protein (BMP) antagonist in early embryogenesis. Loss of BMP antagonism during mammalian development provides a plausible explanation for both the limb and eye phenotype in humans and mice.</p>
      </abstract>
      <abstract abstract-type="summary">
        <title>Author Summary</title>
        <p>Ophthalmo-acromelic syndrome (OAS) is a rare congenital genetic disorder involving complete absence of the eyes and limb malformations, with missing or fused bones in the feet and hands. In this paper we report the identification of genetic changes to both copies of the <italic>SMOC1</italic> gene as the cause of most cases of OAS. We have identified eight different mutations in this gene in unrelated individuals, and six of these mutations are predicted to completely abolish SMOC-1 function. We have also genetically disrupted the mouse <italic>Smoc1</italic> gene to produce only 10% of normal levels. These animals, called <italic>Smoc1<sup>tm1a/tm1a</sup></italic> mice, have similar hindlimb malformations to those seen in the limbs of human OAS patients, resulting in missing toes in some mice and fusion of toes in others. <italic>Smoc1<sup>tm1a/tm1a</sup></italic> embryos and pups also have eye malformations but these are milder than those seen in human cases, perhaps because, unlike the human cases, the mice still have some residual function of the gene. We suggest that the normal function of SMOC-1 may be to regulate an important class of growth factors, called Bone Morphogenetic Proteins (BMPs), which are essential for normal embryonic development.</p>
      </abstract>
      <counts>
        <page-count count="12"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec id="s1">
      <title>Introduction</title>
      <p>Congenital absence of an eye (here termed anophthalmia) is a rare malformation in humans with a live birth prevalence of less than 1 in 10,000 <xref rid="pgen.1002114-Morrison1" ref-type="bibr">[1]</xref>. Identifiable single gene disorders account for â¼25% of bilateral anophthalmia. The known genetic causes include compound heterozygous mutations in <italic>PAX6</italic>, <italic>de novo</italic> heterozygous loss-of-function mutations in <italic>SOX2</italic>
<xref rid="pgen.1002114-Fantes1" ref-type="bibr">[2]</xref>â<xref rid="pgen.1002114-Williamson1" ref-type="bibr">[4]</xref>, inherited or <italic>de novo</italic> heterozygous loss-of-function mutations in <italic>OTX2</italic>
<xref rid="pgen.1002114-Ragge2" ref-type="bibr">[5]</xref>, <xref rid="pgen.1002114-Henderson1" ref-type="bibr">[6]</xref>, homozygous loss-of-function mutations in <italic>STRA6</italic>
<xref rid="pgen.1002114-Pasutto1" ref-type="bibr">[7]</xref> and possibly inherited, heterozygous loss-of-function mutations in <italic>BMP4</italic>
<xref rid="pgen.1002114-Bakrania1" ref-type="bibr">[8]</xref>. In most cases of anophthalmia no eye is visible on clinical examination but optic nerves, chiasm and optic tracts remnants are visible on magnetic resonance imaging. Absence of the eye with ipsilateral absence of optic nerves, chiasm and optic tracts is termed true anophthalmia and is taken to suggest very early failure of ocular development.</p>
      <p>Ophthalmoâacromelic syndrome (OAS), also known as Waardenburg anophthalmia syndrome, is one of the most frequently reported causes of true anophthalmia, which occurs in association with a distinctive pattern of distal limb anomalies (<xref ref-type="fig" rid="pgen-1002114-g001">Figure 1aâ1c</xref>). OAS is an autosomal recessive disorder (MIM #206920) first reported 50 years ago by Waardenburg in two unrelated families <xref rid="pgen.1002114-Waardenburg1" ref-type="bibr">[9]</xref>. This original report illustrated the phenotypic spectrum associated with this disorder. The first family was a sibship of nine and consisted of two sisters with unilateral anophthalmia, one of whom had coloboma in her contralateral eye. Both had bilateral synostosis of the 4th and 5th metacarpals and bilateral postaxial four-toe oligodactyly with soft tissue syndactyly. A brother had similar limb involvement but with normal eyes and the other siblings were reported as normal. In the second family, the proband was a girl with significant learning disability, bilateral anophthalmia, short fingers bilaterally and postaxial oligodactyly with four toes on both feet. Her younger sister was normal. 32 further cases of OAS in 23 different families have been reported <xref rid="pgen.1002114-Abouzeid1" ref-type="bibr">[10]</xref>â<xref rid="pgen.1002114-Traboulsi1" ref-type="bibr">[29]</xref>. Of the reported definite cases; 32/35 (91.4%) had anophthalmia (4â¶28 for unilateral:bilateral), 29 (82.9%) had lower limb postaxial oligodactyly, 20 (57.1%) had fusion of metacarpals 4â5 and 13 (37.1%) had learning disability. Other recurrent features included orofacial clefts (4/35) and perinatal or early postnatal death (10/35) in the 25 families. At the point of submission of this paper, very little was known of the molecular basis of OAS. A locus on 10p11.23 with a reported LOD score &gt;3 had been suggested on the basis of linkage analysis in three unrelated families. However, no pathogenic mutations could be identified in any of the genes in the linkage interval <xref rid="pgen.1002114-Hamanoue1" ref-type="bibr">[17]</xref>.</p>
      <fig id="pgen-1002114-g001" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pgen.1002114.g001</object-id>
        <label>Figure 1</label>
        <caption>
          <title>Mapping ophthalmo-acromelic syndrome.</title>
          <p>Clinical photographs (a,b) and radiographs (c) of patient R14C12 showing bilateral anophthalmia, in association with bilateral postaxial oligodactyly and cutaneous syndactyly of 2<sub>nd</sub> &amp; 3<sub>rd</sub> toes. (d) Multipoint linkage analysis using 10K SNPchip data from families 1â3 showing a significant LOD score of Zâ=â5.3 at 14q22.3â24.2, a region also identified by autozygosity mapping (see <xref ref-type="table" rid="pgen-1002114-t001">Table 1</xref>). (e) Microsatellite marker analysis for affected individuals in Families 1â3 and Family 9 showing region of homozygosity, but no common haplotype. (f) The microsatellite data refined the OAS candidate interval to Chr14â¶69.89â71.26 Mb which is shown diagrammatically with the 22 annotated genes that were sequenced in this study (UCSC assembly GRCh37).</p>
        </caption>
        <graphic xlink:href="pgen.1002114.g001"/>
      </fig>
      <p>Bone morphogenetic proteins (BMPs) account for 10 of the 33 members of the transforming growth factor beta (TGFÎ²) superfamily of peptide growth factors in humans and are encoded by the genes <italic>BMP2-7</italic>, <italic>BMP8A</italic>, <italic>BMP8B</italic>, <italic>BMP10</italic> and <italic>BMP15</italic> (<italic>BMP1</italic> does not encode a growth factor but a tolloid-like protease<xref rid="pgen.1002114-Hopkins1" ref-type="bibr">[30]</xref>). BMPs are secreted into the extracellular space where they bind to BMP type I serine-threonine kinase cell surface receptors encoded by <italic>BMPR1A</italic> and <italic>BMPR1B</italic>. The presence of BMP type I receptors appears sufficient for BMP binding, but a BMP type II receptor (encoded by <italic>BMPR2</italic>, <italic>ACVR2A</italic> and <italic>ACVR2B</italic>) is required for phosphorylation of the BMP type I receptors, endocytosis and activation of the signal transduction cascade <xref rid="pgen.1002114-Sieber1" ref-type="bibr">[31]</xref>. The intracellular domain of the activated BMP type I receptors in turn phosphorylates a Ser-Ser-X-Ser (SSXS) motif at the C-terminal end of one of three homologous protein products of the human genes <italic>SMAD1</italic>, <italic>SMAD5</italic> and <italic>SMAD9</italic>. Phosphorylated SMAD1/5/9 (pSMAD1/5/9 known as regulatory- or R-SMADs) then bind to the co-SMAD encoded by <italic>SMAD4.</italic> The co-SMAD/R-SMAD complex then translocates to the nucleus where it functions as a transcription factor mediating the activation of target genes <xref rid="pgen.1002114-Miyazono1" ref-type="bibr">[32]</xref>. It has recently become clear that BMP signaling can also directly induce the activation of the MAPK pathway <xref rid="pgen.1002114-Hu1" ref-type="bibr">[33]</xref>.</p>
      <p>The formation of BMP signaling gradients is used extensively throughout vertebrate embryonic development. The formation and maintenance of stable developmental gradients appears to require multiple mechanisms to balance agonistic and antagonist effects on BMP signaling. The complexity of the system is demonstrated by the molecular basis of dorsal and ventral signaling centres in the gastrula of <italic>Xenopus laevis</italic> embryos <xref rid="pgen.1002114-DeRobertis1" ref-type="bibr">[34]</xref>. The dorsal signaling centre (DSC; Spemann's organizer) has the general effect of antagonizing the Bmp gradient from the ventral signaling centre. The DSC secretes noggin and chordin, which (together with twisted-gastrulation <xref rid="pgen.1002114-Wills1" ref-type="bibr">[35]</xref>) bind to bmp in the extracellular space and prevents binding to the bmp type I receptor. The ventral signaling centre (VSC) secretes bmp4 and bmp7 but also bmper (bmp-binding endothelial regulator) <xref rid="pgen.1002114-Ambrosio1" ref-type="bibr">[36]</xref> and sizzled, which inhibits tolloid-like 1, a zinc metalloproteinase that efficiently cleaves chordin <xref rid="pgen.1002114-Dale1" ref-type="bibr">[37]</xref>. The VSC also produces bambi (bmp and activin membrane-bound inhibitor), a bmp receptor that lacks the catalytic intracellular domain and thus acts dominant-negatively to inhibit bmp signaling <xref rid="pgen.1002114-Yan1" ref-type="bibr">[38]</xref>.</p>
      <p>SMOC-1 is encoded by the human gene <italic>SMOC1</italic> (<italic>SPARC related modular calcium binding 1</italic>) and was initially characterised as a basement membrane protein with significant homology to BM-40 (also known as SPARC and osteonectin) <xref rid="pgen.1002114-Vannahme1" ref-type="bibr">[39]</xref>. The domain structure of the SMOC-1 peptide and the close homolog SMOC-2 <xref rid="pgen.1002114-Vannahme2" ref-type="bibr">[40]</xref>, is evolutionarily conserved <xref rid="pgen.1002114-Novinec1" ref-type="bibr">[41]</xref> and consists from N- to C-terminus of a follistatin-like domain, two thyroglobulin type I (Tg1) domains and an EF-hand calcium-binding domain. The ortholog of SMOC-1 in <italic>Xenopus laevis</italic>, XSMOC-1, has been shown to function as a BMP antagonist. Uniquely among the known peptide BMP antagonists, SMOC-1 was able to antagonize BMP activity in the presence of a constitutively active BMP receptor. The molecular basis of this antagonism is not yet clear but may function by stimulating MAPK-mediated phosphorylation of the linker (i.e. non-SSXS) region of the R-SMAD proteins <xref rid="pgen.1002114-Thomas1" ref-type="bibr">[42]</xref>.</p>
      <p>We report the identification of a locus for OAS on 14q24.2 with subsequent identification of homozygous, predicted loss-of-function mutations in the <italic>SMOC1</italic> gene in eight out of fourteen unrelated families with OAS. Whole mount <italic>in situ</italic> hybridisation (WISH) combined with optical projection tomography (OPT) shows site- and stage-specific developmental expression of the orthologous mouse gene, <italic>Smoc1,</italic> in embryonic limb bud and craniofacial structures. The phenotype associated with homozygosity for a targeted âpre-conditionalâ gene-trap mouse mutation of <italic>Smoc1</italic> also shows significant overlap with the human disease. SMOC-1 and SMOC-2 appear to be the two vertebrate paralogs of the <italic>Drosophila</italic> protein Pentagone that has recently been shown to function as an antagonist of Decapentaplegic (Dpp) signaling <italic>in vivo</italic>
<xref rid="pgen.1002114-Hu1" ref-type="bibr">[33]</xref>. We discuss the potential role for SMOC-1 in modulating BMP signaling during eye and limb development.</p>
    </sec>
    <sec id="s2">
      <title>Results</title>
      <sec id="s2a">
        <title>Mapping and Mutation Analysis</title>
        <p>A locus for OAS at 14q24.2 was identified using autozygosity mapping with 10K SNP chip data from multiple, apparently unrelated consanguineous pedigrees. Affected individuals from eight of the fourteen families showed tracks of &gt;20 homozygous SNPs in a row at this locus (<xref ref-type="supplementary-material" rid="pgen.1002114.s006">Dataset S1</xref>). This locus was confirmed with multipoint linkage analysis using data from three of these families giving a combined LOD score of 5.3 (<xref ref-type="fig" rid="pgen-1002114-g001">Figure 1d</xref>). The critical region was narrowed to â¼1 Mb using microsatellite markers in four families (<xref ref-type="fig" rid="pgen-1002114-g001">Figure 1e</xref>). To identify the causative gene, all coding exons for each gene in the critical region were sequenced (<xref ref-type="fig" rid="pgen-1002114-g001">Figure 1f</xref>).</p>
        <p>Potentially deleterious mutations were identified in only one gene: <italic>SMOC1,</italic> and independent homozygous <italic>SMOC1</italic> mutations were found in eight out of fourteen families (<xref ref-type="fig" rid="pgen-1002114-g002">Figure 2a</xref>, <xref ref-type="table" rid="pgen-1002114-t001">Table 1</xref>). Of these, 6 mutations predicted complete loss of protein function; 4 are nonsense mutations and 2 are single base deletions or insertions resulting in a frameshift. Two different missense changes were identified, both are in the C-terminal region of the second thyroglobulin type I domain of SMOC-1 (<xref ref-type="fig" rid="pgen-1002114-g002">Figure 2b</xref>). No mutations were identified in sequence analysis of the <italic>SMOC1</italic> coding region in 190 healthy blood donors.</p>
        <fig id="pgen-1002114-g002" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pgen.1002114.g002</object-id>
          <label>Figure 2</label>
          <caption>
            <title>Mutation analysis.</title>
            <p>(a) Family pedigrees and associated <italic>SMOC1</italic> mutations identified. The pedigree for Family 1 is representative and shows segregation of a homozygous <italic>SMOC1</italic> mutation (c.911delG; p.Asp305MetfsX59) in affected individuals with both parents (and all unaffected sibs) being heterozygous carriers. (b) Schematic of the <italic>SMOC1</italic> gene (top) and predicted protein (below), illustrating the exon positions for all eight mutations identified in the OAS families. Coding exons are coloured black and numbered, UTRs are brown, protein domains are labeled with amino acid residue numbers. Red arrowheads indicate the position of the mutations in the peptide. Red asterisks highlight the missense changes, which are located in the second thyroglobulin domain thought to be involved in the control of proteolytic degradation (n.t.- Sample not tested).</p>
          </caption>
          <graphic xlink:href="pgen.1002114.g002"/>
        </fig>
        <table-wrap id="pgen-1002114-t001" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pgen.1002114.t001</object-id>
          <label>Table 1</label>
          <caption>
            <title>Clinical features and mutations in affected individuals with Ophthalmo-Acromelic Syndrome.</title>
          </caption>
          <alternatives>
            <graphic id="pgen-1002114-t001-1" xlink:href="pgen.1002114.t001"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <td align="left" rowspan="1" colspan="1">FAMILY</td>
                  <td align="left" rowspan="1" colspan="1">1</td>
                  <td align="left" rowspan="1" colspan="1">2</td>
                  <td align="left" rowspan="1" colspan="1">3</td>
                  <td align="left" rowspan="1" colspan="1">4</td>
                  <td align="left" rowspan="1" colspan="1">5</td>
                  <td align="left" rowspan="1" colspan="1">6</td>
                  <td align="left" rowspan="1" colspan="1">7</td>
                  <td align="left" rowspan="1" colspan="1">8</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Affected Case</td>
                  <td align="left" rowspan="1" colspan="1">R14A9</td>
                  <td align="left" rowspan="1" colspan="1">R14C12</td>
                  <td align="left" rowspan="1" colspan="1">R15H11</td>
                  <td align="left" rowspan="1" colspan="1">R23H3</td>
                  <td align="left" rowspan="1" colspan="1">17715</td>
                  <td align="left" rowspan="1" colspan="1">18177</td>
                  <td align="left" rowspan="1" colspan="1">15124</td>
                  <td align="left" rowspan="1" colspan="1">20384</td>
                  <td align="left" rowspan="1" colspan="1">20386</td>
                  <td align="left" rowspan="1" colspan="1">30433</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Published</td>
                  <td align="left" rowspan="1" colspan="1">Unpublished</td>
                  <td align="left" rowspan="1" colspan="1">Garavelli et al., (2006)</td>
                  <td align="left" rowspan="1" colspan="1">Khan &amp; Zafar, (2008)</td>
                  <td align="left" rowspan="1" colspan="1">Suyugul et al, (1996) (case 3)</td>
                  <td align="left" rowspan="1" colspan="1">Pallotta &amp; Dallapiccola, (1984)</td>
                  <td align="left" rowspan="1" colspan="1">Unpublished</td>
                  <td align="left" rowspan="1" colspan="1">Sayli et al. (1995)</td>
                  <td align="left" rowspan="1" colspan="1">Pallotta &amp; Dallapiccola, (1984)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Age assessed</td>
                  <td align="left" rowspan="1" colspan="1">13 Yr</td>
                  <td align="left" rowspan="1" colspan="1">9 Yr</td>
                  <td align="left" rowspan="1" colspan="1">6 Mo</td>
                  <td align="left" rowspan="1" colspan="1">7 Mo</td>
                  <td align="left" rowspan="1" colspan="1">18 Yr</td>
                  <td align="left" rowspan="1" colspan="1">40 Yr</td>
                  <td align="left" rowspan="1" colspan="1">11 Yr</td>
                  <td align="left" rowspan="1" colspan="1">14 Yr</td>
                  <td align="left" rowspan="1" colspan="1">7 Yr</td>
                  <td align="left" rowspan="1" colspan="1">10 Yr</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Sex (Ratio)</td>
                  <td align="left" rowspan="1" colspan="1">M</td>
                  <td align="left" rowspan="1" colspan="1">M</td>
                  <td align="left" rowspan="1" colspan="1">M</td>
                  <td align="left" rowspan="1" colspan="1">F</td>
                  <td align="left" rowspan="1" colspan="1">M</td>
                  <td align="left" rowspan="1" colspan="1">M</td>
                  <td align="left" rowspan="1" colspan="1">F</td>
                  <td align="left" rowspan="1" colspan="1">M</td>
                  <td align="left" rowspan="1" colspan="1">M</td>
                  <td align="left" rowspan="1" colspan="1">M</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Ethnicity</td>
                  <td align="left" rowspan="1" colspan="1">Lebanese</td>
                  <td align="left" rowspan="1" colspan="1">Lebanese</td>
                  <td align="left" rowspan="1" colspan="1">Gypsy</td>
                  <td align="left" rowspan="1" colspan="1">Pakistani</td>
                  <td align="left" rowspan="1" colspan="1">Turkish</td>
                  <td align="left" rowspan="1" colspan="1">Calabrian</td>
                  <td align="left" rowspan="1" colspan="1">Puerto Rican</td>
                  <td align="left" rowspan="1" colspan="1">Turkish</td>
                  <td align="left" rowspan="1" colspan="1">Sicilian</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Consanguinity</td>
                  <td align="left" rowspan="1" colspan="1">+</td>
                  <td align="left" rowspan="1" colspan="1">+</td>
                  <td align="left" rowspan="1" colspan="1">+</td>
                  <td align="left" rowspan="1" colspan="1">+</td>
                  <td align="left" rowspan="1" colspan="1">+</td>
                  <td align="left" rowspan="1" colspan="1">+</td>
                  <td align="left" rowspan="1" colspan="1">â</td>
                  <td align="left" rowspan="1" colspan="1">+</td>
                  <td align="left" rowspan="1" colspan="1">+</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Ocular defect</td>
                  <td align="left" rowspan="1" colspan="1">None</td>
                  <td align="left" rowspan="1" colspan="1">BA</td>
                  <td align="left" rowspan="1" colspan="1">BA</td>
                  <td align="left" rowspan="1" colspan="1">UA</td>
                  <td align="left" rowspan="1" colspan="1">BA</td>
                  <td align="left" rowspan="1" colspan="1">BA</td>
                  <td align="left" rowspan="1" colspan="1">BA</td>
                  <td align="left" rowspan="1" colspan="1">BA</td>
                  <td align="left" rowspan="1" colspan="1">BA</td>
                  <td align="left" rowspan="1" colspan="1">BA</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Optic nerve/tract/chiasm present on scan?</td>
                  <td align="left" rowspan="1" colspan="1">â</td>
                  <td align="left" rowspan="1" colspan="1">Unknown</td>
                  <td align="left" rowspan="1" colspan="1">Remnants of optic nerve</td>
                  <td align="left" rowspan="1" colspan="1">Unknown</td>
                  <td align="left" rowspan="1" colspan="1">Absent</td>
                  <td align="left" rowspan="1" colspan="1">Absent</td>
                  <td align="left" rowspan="1" colspan="1">Unknown</td>
                  <td align="left" rowspan="1" colspan="1">Unknown</td>
                  <td align="left" rowspan="1" colspan="1">Unknown</td>
                  <td align="left" rowspan="1" colspan="1">Absent</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Upper limb</td>
                  <td align="left" rowspan="1" colspan="1">cut synd</td>
                  <td align="left" rowspan="1" colspan="1">cut synd, hypopl 5<sup>th</sup> finger</td>
                  <td align="left" rowspan="1" colspan="1">bilat 4/5 metacarpal fusion</td>
                  <td align="left" rowspan="1" colspan="1">â</td>
                  <td align="left" rowspan="1" colspan="1">bilat 4/5 metacarpal fusion, camptodactyly</td>
                  <td align="left" rowspan="1" colspan="1">bilat 4/5 metacarpal fusion</td>
                  <td align="left" rowspan="1" colspan="1">contractures of fingers</td>
                  <td align="left" rowspan="1" colspan="1">short 5<sup>th</sup> metacarpals</td>
                  <td align="left" rowspan="1" colspan="1">short 5<sup>th</sup> metacarpals</td>
                  <td align="left" rowspan="1" colspan="1">clinodactyly 5th fingers</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Lower Limb</td>
                  <td align="left" rowspan="1" colspan="1">cut synd 3â5</td>
                  <td align="left" rowspan="1" colspan="1">bilat missing postaxial ray cut synd 2â4 right, 2/3 left</td>
                  <td align="left" rowspan="1" colspan="1">bilat missing postaxial ray</td>
                  <td align="left" rowspan="1" colspan="1">bilat missing postaxial ray</td>
                  <td align="left" rowspan="1" colspan="1">bilat missing postaxial ray</td>
                  <td align="left" rowspan="1" colspan="1">bilat missing postaxial ray</td>
                  <td align="left" rowspan="1" colspan="1">bilat missing postaxial ray &amp; cut synd 2/3</td>
                  <td align="left" rowspan="1" colspan="1">Right fusion 4/5 metatarsal &amp; phalanx, cut synd 2â5</td>
                  <td align="left" rowspan="1" colspan="1">cut synd toes 2â5</td>
                  <td align="left" rowspan="1" colspan="1">cut synd toes 4/5</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Other Limb/Skeletal Defect</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">Bowed tibia</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">Contractures of elbows, Coxa valga</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">TEV, bowed tibias</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Craniofacial</td>
                  <td align="left" rowspan="1" colspan="1">â</td>
                  <td align="left" rowspan="1" colspan="1">Cleft palate</td>
                  <td align="left" rowspan="1" colspan="1">â</td>
                  <td align="left" rowspan="1" colspan="1">Pierre Robin Sequence</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">Highly arched palate</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Other defects</td>
                  <td align="left" rowspan="1" colspan="1">Horseshoe kidney, hypospadias</td>
                  <td align="left" rowspan="1" colspan="1">Horseshoe kidney, mental retardation</td>
                  <td align="left" rowspan="1" colspan="1">Horseshoe kidney</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">Severe mental retardation, epilepsy, cryptorchidism</td>
                  <td align="left" rowspan="1" colspan="1">Severe mental retardation</td>
                  <td align="left" rowspan="1" colspan="1">Horseshoe kidney</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">Severe mental retardation</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Coding change</td>
                  <td align="left" rowspan="1" colspan="1">c.911delG</td>
                  <td align="left" rowspan="1" colspan="1">c.911delG</td>
                  <td align="left" rowspan="1" colspan="1">c.395dupA</td>
                  <td align="left" rowspan="1" colspan="1">c.212C&gt;T</td>
                  <td align="left" rowspan="1" colspan="1">c.1109C&gt;T</td>
                  <td align="left" rowspan="1" colspan="1">c.224C&gt;T</td>
                  <td align="left" rowspan="1" colspan="1">c.275C&gt;T</td>
                  <td align="left" rowspan="1" colspan="1">c.848C&gt;A</td>
                  <td align="left" rowspan="1" colspan="1">c.848C&gt;A</td>
                  <td align="left" rowspan="1" colspan="1">c.833C&gt;T</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Protein change</td>
                  <td align="left" rowspan="1" colspan="1">p.Asp305MetfsX5</td>
                  <td align="left" rowspan="1" colspan="1">p.Asp305MetfsX5</td>
                  <td align="left" rowspan="1" colspan="1">p.Tyr132fsX1</td>
                  <td align="left" rowspan="1" colspan="1">p.Arg71X</td>
                  <td align="left" rowspan="1" colspan="1">p.Gln370X</td>
                  <td align="left" rowspan="1" colspan="1">p.Arg75X</td>
                  <td align="left" rowspan="1" colspan="1">p.Gln92X</td>
                  <td align="left" rowspan="1" colspan="1">p.Thr283Asn</td>
                  <td align="left" rowspan="1" colspan="1">p.Thr283Asn</td>
                  <td align="left" rowspan="1" colspan="1">p.Arg278Cys</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Exon</td>
                  <td align="left" rowspan="1" colspan="1">9</td>
                  <td align="left" rowspan="1" colspan="1">9</td>
                  <td align="left" rowspan="1" colspan="1">4</td>
                  <td align="left" rowspan="1" colspan="1">2</td>
                  <td align="left" rowspan="1" colspan="1">11</td>
                  <td align="left" rowspan="1" colspan="1">2</td>
                  <td align="left" rowspan="1" colspan="1">3</td>
                  <td align="left" rowspan="1" colspan="1">8</td>
                  <td align="left" rowspan="1" colspan="1">8</td>
                  <td align="left" rowspan="1" colspan="1">8</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Mutation Type</td>
                  <td align="left" rowspan="1" colspan="1">Frameshift 2</td>
                  <td align="left" rowspan="1" colspan="1">Frameshift 2</td>
                  <td align="left" rowspan="1" colspan="1">Frameshift 1</td>
                  <td align="left" rowspan="1" colspan="1">Nonsense 1</td>
                  <td align="left" rowspan="1" colspan="1">Nonsense 2</td>
                  <td align="left" rowspan="1" colspan="1">Nonsense 3</td>
                  <td align="left" rowspan="1" colspan="1">Nonsense 4</td>
                  <td align="left" rowspan="1" colspan="1">Missense 1</td>
                  <td align="left" rowspan="1" colspan="1">Missense 1</td>
                  <td align="left" rowspan="1" colspan="1">Missense 2</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">IBD 14q24.2</td>
                  <td align="left" rowspan="1" colspan="1">Yes</td>
                  <td align="left" rowspan="1" colspan="1">Yes</td>
                  <td align="left" rowspan="1" colspan="1">Yes</td>
                  <td align="left" rowspan="1" colspan="1">Yes</td>
                  <td align="left" rowspan="1" colspan="1">Yes</td>
                  <td align="left" rowspan="1" colspan="1">Yes</td>
                  <td align="left" rowspan="1" colspan="1">Yes</td>
                  <td align="left" rowspan="1" colspan="1">Yes</td>
                  <td align="left" rowspan="1" colspan="1">Yes</td>
                  <td align="left" rowspan="1" colspan="1">Yes</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="nt101">
              <label/>
              <p>Yrâ=âyears; Moâ=âmonths; Fâ=âFemale; Mâ=âMale; UA/BAâ=âUnilateral/Bilateral anophthalmia; IBDâ=âIdentity by Descent; Cut syndâ=âcutaneous syndactyly; TEVâ=âtalipes equinovarus; 2/3â=âsecond and third digits; 3â5â=âthird, fourth and fifth digits; 2â4â=âsecond third and fourth digits; 2â5â=âsecond, third, fourth and fifth digits; 4/5â=âfourth and fifth digits; bilatâ=âbilateral.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>No mutations in <italic>SMOC1</italic> could be identified in 6 of the 14 families. There were no obvious phenotypic differences between the cases with and without <italic>SMOC1</italic> mutations; all have classical OAS. SNP and microsatellite data on two of the six families without detectable mutations showed large regions of homozygosity across the 14q24 region containing <italic>SMOC1.</italic> This suggests that we have missed a mutation within the transcription unit or that there may be a regulatory mutation impairing <italic>SMOC1</italic> transcription. In the four remaining families no plausible locus could be identified using homozygosity mapping.</p>
      </sec>
      <sec id="s2b">
        <title>Expression Analysis of <italic>Smoc1</italic>
</title>
        <p>As a first step to determining the likely developmental role of <italic>SMOC1</italic> we undertook developmental expression analysis of the orthologous gene <italic>Smoc1</italic> in whole mouse embryos. WISH analysis with an antisense riboprobe specific to <italic>Smoc1</italic> and optical projection tomography (OPT) were used to create a 3D representation of both the anatomy and colorimetric staining. We found site- and stage-specific expression of <italic>Smoc1</italic> at all stages examined (<xref ref-type="fig" rid="pgen-1002114-g003">Figure 3aâ3b</xref>; <xref ref-type="supplementary-material" rid="pgen.1002114.s004">Video S1</xref>; <xref ref-type="supplementary-material" rid="pgen.1002114.s005">Video S2</xref>). Staining in the limb bud was particularly interesting with expression seen first in the very early limb bud anlage from 9.5 dpc (<xref ref-type="fig" rid="pgen-1002114-g003">Figure 3a</xref>). At 10.5 dpc the limb expression distinctly localised to both the dorsal and ventral surfaces of the forelimb, but was predominantly dorsal in the hindlimb bud (<xref ref-type="fig" rid="pgen-1002114-g003">Figure 3b</xref>, <xref ref-type="supplementary-material" rid="pgen.1002114.s001">Figure S1</xref>). Strong expression was seen in the developing pharyngeal arches and the frontonasal region with low-level expression in the ectoderm overlying the developing optic vesicle (<xref ref-type="supplementary-material" rid="pgen.1002114.s001">Figure S1</xref>). Using WISH and OPT no clear expression of <italic>Smoc1</italic> was detected in the optic vesicle itself. There was clear expression in the developing somites at E9.5 and E10.5 (<xref ref-type="fig" rid="pgen-1002114-g003">Figure 3a, 3b</xref>). At E9.5 there was also staining in the hindbrain (<xref ref-type="fig" rid="pgen-1002114-g003">Figure 3a</xref>) and at E10.5 strong staining in the dorsal neural tube (<xref ref-type="fig" rid="pgen-1002114-g003">Figure 3b</xref>).</p>
        <fig id="pgen-1002114-g003" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pgen.1002114.g003</object-id>
          <label>Figure 3</label>
          <caption>
            <title>A targeted <italic>Smoc1</italic> mutation caused an ophthalmo-acromelic-like phenotype in mice.</title>
            <p>(a) OPT representation of wild type (WT) <italic>Smoc1</italic> expression at embryonic day (E) 9.5 (green represents <italic>Smoc1</italic> expression); <italic>Smoc1</italic> is expressed in the pharyngeal (branchial) arches (BA), the rostral neural tube (NT), in the anlage of the forelimbs (FL), the fronto-nasal region (FN), and in the somites (S). (b) At E10.5, expression is maintained in the branchial arches, somites and in the frontal nasal processes, as well as extending caudally in the neural tube. (c) In E10.5 <italic>Smoc1<sup>tm1a/tm1a</sup></italic> embryos, Î²-galactosidase activity was observed in tissues consistent with the OPT analysis of WT <italic>Smoc1</italic> expression: in the dorsal hindlimbs; in the medial regions of dorsal and ventral forelimbs, the branchial arches, in the frontonasal processes, and in the somites. In addition, strong signal was observed in the eye region (scale barâ=â500 Âµm). (d) X-gal stained sagittal sections of a representative E10.5 <italic>Smoc1<sup>tm1a/tm1a</sup></italic> embryo in the developing eye showing that expression was restricted to ventral regions of the presumptive optic stalk (POS). (e) Examination of optic nerve morphology identified an extension of the RPE into the dorsal optic nerve in mutant animals compared to control. (f) Photographs of <italic>Smoc1<sup>tm1a/tm1a</sup></italic> eye showing an optic fissure closure defect (arrowhead) consistent with coloboma (scale barsâ=â100 Âµm). (g) Expression in the 1<sup>st</sup> branchial arch mesenchyme was distributed in proximal regions and absent from distal areas, with positive signal also seen in the epithelial cells at the hinge region between maxilliary (MX) and mandibular (MD) components (arrowheads) (scale barâ=â100 Âµm). (h,i) Pictomicrographs of sections through E14.5 heads showing a failure in palatal shelf (PS) fusion in the developing palate in the <italic>Smoc1<sup>tm1a/tm1a</sup></italic> embryo (i) compared to the fully fused WT littermate (h). (j,k) Surface rendered visualization of OPT reconstructions of hindlimbs at E14.5. (j) WT embryo with normal arrangement of 5 digits in the hindlimb whereas the <italic>Smoc1<sup>tm1a/tm1a</sup></italic> littermate (k) had hindlimb oligodactyly affecting the axial digits, with only 4 digits present. (l) Skeletal preparation of P0 <italic>Smoc1<sup>tm1a/tm1a</sup></italic> hindlimb with osseous fusion of the phalanges of digits 3â4 (red arrow).</p>
          </caption>
          <graphic xlink:href="pgen.1002114.g003"/>
        </fig>
      </sec>
      <sec id="s2c">
        <title>Targeted Mutation in Mouse <italic>Smoc1</italic>
</title>
        <p>In order to determine if the non-redundant developmental role of <italic>SMOC1</italic> is evolutionarily conserved we obtained mice with a targeted Pre-Conditional mutation in <italic>Smoc1</italic> containing a <italic>LacZ</italic> reporter allele created as part of the EUCOMM project <xref rid="pgen.1002114-Friedel1" ref-type="bibr">[43]</xref>. The integrated location and the details of the targeting construct are shown in <xref ref-type="supplementary-material" rid="pgen.1002114.s001">Figure S1d</xref>. The <italic>Smoc1<sup>tm1a/tm1a</sup></italic> mice have â¼10% of wild-type levels of <italic>Smoc1</italic> mRNA during development (<xref ref-type="supplementary-material" rid="pgen.1002114.s001">Figure S1f</xref>), presumably as a result of splicing across the gene-trap insertion.</p>
        <p>Using the <italic>LacZ</italic> reporter in targeted animals, we were able to further assess the developmental expression of <italic>Smoc1</italic> (<xref ref-type="fig" rid="pgen-1002114-g003">Figure 3c, 3d, and 3g</xref>). Spatial and temporal expression data were similar between <italic>Smoc1<sup>+/tm1a</sup></italic> and <italic>Smoc1<sup>tm1a/tm1a</sup></italic> genotypes, but with less intense staining in <italic>Smoc1<sup>+/tm1a</sup></italic> mice (data not shown). The X-gal staining at E10.5 of both whole mount embryos and cryosections was consistent with the wild type OPT data. Cryosections through the maxilliary-mandibular hinge region of the 1<sup>st</sup> pharyngeal (branchial) arch at E10.5 showed striking regional specificity of gene activation (<xref ref-type="fig" rid="pgen-1002114-g003">Figure 3g</xref>). The expression was present within the mesenchyme or neural crest of both components of the first arch but is most intense in the sub-epithelial mesenchyme within the hinge region. Sharp boundaries of expression are evident in the subepithelial mesenchyme (<xref ref-type="fig" rid="pgen-1002114-g003">Figure 3g</xref>). The only major difference between the riboprobe WISH analysis and the X-gal staining was the strong expression identified within the developing eye seen in the latter but not the former (<xref ref-type="fig" rid="pgen-1002114-g003">Figure 3c</xref>). This staining was particularly strong at E10.5 within the ventral aspect of the developing optic nerve (<xref ref-type="fig" rid="pgen-1002114-g003">Figure 3d</xref>).</p>
        <p>Further phenotypic analysis of mutant animals showed that limb malformations were present in a high proportion of embryos and pups (<xref ref-type="table" rid="pgen-1002114-t002">Table 2</xref>). Oligodactyly (+/â fibular agenesis) or osseous syndactyly of both hindlimbs was present in 11/12 of <italic>Smoc1<sup>tm1a/tm1a</sup></italic> animals (<xref ref-type="fig" rid="pgen-1002114-g003">Figure 3jâ3k</xref> and <xref ref-type="supplementary-material" rid="pgen.1002114.s001">Figure S1</xref>). <italic>Smoc1<sup>tm1a/tm1a</sup></italic> embryos and neonates were also smaller than littermates but did not appear to have any other major malformations (<xref ref-type="supplementary-material" rid="pgen.1002114.s002">Figure S2</xref>). To date all <italic>Smoc1<sup>tm1a/tm1a</sup></italic> animals allowed to litter have died at or soon after birth. A proportion of this perinatal lethality is likely be related to the presence of cleft palate in a significant proportion (4 of 12) of the <italic>Smoc1<sup>tm1a/tm1a</sup></italic> animals (<xref ref-type="fig" rid="pgen-1002114-g003">Figure 3i</xref>). However it is not clear what accounts for the mortality in the non-cleft cases. Interestingly, unexplained perinatal lethality is reported in human OAS families (see <xref ref-type="sec" rid="s1">Introduction</xref>).</p>
        <table-wrap id="pgen-1002114-t002" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pgen.1002114.t002</object-id>
          <label>Table 2</label>
          <caption>
            <title>Phenotypes identified in <italic>Smoc1-</italic>targeted mice.</title>
          </caption>
          <alternatives>
            <graphic id="pgen-1002114-t002-2" xlink:href="pgen.1002114.t002"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Genotype</td>
                  <td align="left" rowspan="1" colspan="1">
<italic>Smoc1<sup>tm1a/tm1a</sup></italic>
</td>
                  <td align="left" rowspan="1" colspan="1">
<italic>Smoc1<sup>+/tm1a</sup></italic>
</td>
                  <td align="left" rowspan="1" colspan="1">
<italic>Smoc1<sup>+/+</sup></italic>
</td>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Total analysed</td>
                  <td align="left" rowspan="1" colspan="1">12 (26%)</td>
                  <td align="left" rowspan="1" colspan="1">21 (45.7%)</td>
                  <td align="left" rowspan="1" colspan="1">13 (28.3%)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Eye phenotype</td>
                  <td align="left" rowspan="1" colspan="1">5 (nâ=â9<xref ref-type="table-fn" rid="nt102">*</xref>; 55.6%)</td>
                  <td align="left" rowspan="1" colspan="1">0</td>
                  <td align="left" rowspan="1" colspan="1">0</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Hind limb phenotype</td>
                  <td align="left" rowspan="1" colspan="1">11 (91.7%)</td>
                  <td align="left" rowspan="1" colspan="1">0</td>
                  <td align="left" rowspan="1" colspan="1">0</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Cleft palate</td>
                  <td align="left" rowspan="1" colspan="1">4 (33.3%)</td>
                  <td align="left" rowspan="1" colspan="1">0</td>
                  <td align="left" rowspan="1" colspan="1">0</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Missing fibula</td>
                  <td align="left" rowspan="1" colspan="1">6 (50%)</td>
                  <td align="left" rowspan="1" colspan="1">0</td>
                  <td align="left" rowspan="1" colspan="1">0</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="nt102">
              <label/>
              <p>*3 confirmed <italic>Smoc1<sup>tm1a/tm1a</sup></italic> animals were embedded in paraffin before eye phenotype was established.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>Eye malformations were apparent in a significant proportion of the homozygous embryos or pups. We observed iris and retinal coloboma in 55.6% of the homozygous animals that could be accurately phenotyped (<xref ref-type="fig" rid="pgen-1002114-g003">Figure 3f</xref>). Extension of the retinal pigmented epithelium (RPE) into the optic nerve (<xref ref-type="fig" rid="pgen-1002114-g003">figure 3e</xref>), and a reduction in optic nerve diameters (<xref ref-type="supplementary-material" rid="pgen.1002114.s002">Figure S2</xref>) was also observed in these mice.</p>
      </sec>
    </sec>
    <sec id="s3">
      <title>Discussion</title>
      <p>We report compelling evidence that loss-of-function mutations in <italic>SMOC1</italic> cause a significant subset of OAS cases. No non-synonymous changes were found in any region of the <italic>SMOC1</italic> coding region in the 190 control individuals that were fully sequenced but we identified eight mutations within OAS families that are all different and homozygous. Six of these mutations (four nonsense and two frame-shift) are very likely to result in severe or complete abrogation of protein function. The two missense mutations (p.Arg278Cys &amp; p.Thr283Asn) we have identified are both located in the second thyroglobulin type-1 domain (Tg1) of SMOC-1. Tg1 domains are cysteine-rich motifs that were first identified in the C-terminal region of thyroglobulin which appear to function as peptidase inhibitors, specifically inhibitors of cysteine cathepsins <xref rid="pgen.1002114-Hitzel1" ref-type="bibr">[44]</xref>, <xref rid="pgen.1002114-Pungercic1" ref-type="bibr">[45]</xref>. Neither Arg278 or Thr283 show identity at the equivalent residue within the first Tg1 in human SMOC-1. However, both residues show complete conservation with the second Tg1 in both mouse and <italic>Xenopus tropicalis</italic> Smoc-1 and Thr283 is conserved in the second Tg1 in <italic>Drosophila</italic> Pentagone (see <xref ref-type="supplementary-material" rid="pgen.1002114.s003">Figure S3</xref>). The mutation of Arg278 to Cys may disrupt the highly conserved pattern of disulphide bonding within the second Tg1 <xref rid="pgen.1002114-Novinec1" ref-type="bibr">[41]</xref>. Given that there is no obvious difference between the missense mutation cases and those with null mutations, it is reasonable to speculate that inhibition of a developmentally expressed peptidase, possibly a cysteine cathepsin, may be the non-redundant developmental function of SMOC-1. Interestingly, Cathepsin H has been shown to be involved in Bmp4 degradation during lung development <xref rid="pgen.1002114-Lu1" ref-type="bibr">[46]</xref>. It is also possible that a mutation resulting in constitutive activation of the target peptidase could phenocopy <italic>SMOC1</italic> mutations.</p>
      <p>The expression analysis and targeted partial gene inactivation in mouse embryos strongly supports the critical and non-redundant developmental role of SMOC-1 suggested by the human genetic analysis and that this role is conserved across evolutionary time. The hindlimb phenotype in <italic>Smoc1<sup>tm1a/tm1a</sup></italic> homozygous mice was very similar to the lower limb phenotype in human OAS cases. The combination of osseous syndactyly and oligodactyly suggest that the mechanisms controlling digit number within the limb bud are significantly impaired. The control of digit number is critically dependent on correct dosage of sonic hedghog (Shh) <xref rid="pgen.1002114-Stopper1" ref-type="bibr">[47]</xref>, <xref rid="pgen.1002114-Towers1" ref-type="bibr">[48]</xref> and BMP4 &amp; BMP7 signaling proteins <xref rid="pgen.1002114-Katagiri1" ref-type="bibr">[49]</xref>, <xref rid="pgen.1002114-Robert1" ref-type="bibr">[50]</xref>. A significant proportion of the <italic>Smoc1<sup>tm1a/tm1a</sup></italic> homozygous mice have cleft palate, a feature common to human OAS and consistent with the high level of expression of <italic>Smoc1</italic> that was detected in the developing first pharyngeal arch. The eye malformations seen in the mouse were less severe than those seen in human OAS cases, being predominantly iris and retinal coloboma. This may relate to the difference in mutation type between the mouse and human cases: most human mutations are apparently null, whereas the mouse line had 10% of normal <italic>Smoc1</italic> transcript levels present, most likely due to splicing across the gene trap. This level of Smoc-1 function could partially rescue the ocular phenotype in the mice. Analysis of the phenotype associated with a null allele in mice that we are currently making will answer this question. We will also screen a cohort of human patients to determine if hypomorphic mutations in <italic>SMOC1</italic> may cause coloboma.</p>
      <p>The formation of precise gradients of diffusible ligands is required during embryogenesis both for patterning - the formation of complex tissue structures from apparently homogenous populations of multipotent cells - and to control growth to achieve correct final organ size with appropriate symmetry of paired structures. BMPs represent an important class of diffusible ligands with roles in both patterning and control of organ size <xref rid="pgen.1002114-Ashe1" ref-type="bibr">[51]</xref>, <xref rid="pgen.1002114-Schwank1" ref-type="bibr">[52]</xref>. Much of what we know about the formation, maintenance and function of BMP gradients derived from studies of <italic>Drosophila</italic> Decapentaplegic (Dpp) <xref rid="pgen.1002114-Affolter1" ref-type="bibr">[53]</xref>. BMPs are considered to be the mammalian paralogs of Dpp. SMOC-1 and its close homolog SMOC-2 appear to be the mammalian paralogs of <italic>Drosophila</italic> Pentagone (Pent) <xref rid="pgen.1002114-Vuilleumier1" ref-type="bibr">[54]</xref>. Pent functions as an <italic>in vivo</italic> antagonist of Dpp by preventing receptor endocytosis close to its source thus allowing gradients to form over wider distances within the wing imaginal discs. Lack of Pent results in a very steep and narrow gradient of Dpp signaling, which in turn causes a relative deficiency of Dpp further from the source. In <italic>Drosophila</italic> the control of cell proliferation within the wing imaginal disc is dependent on Dpp signaling <xref rid="pgen.1002114-Rogulja1" ref-type="bibr">[55]</xref>. In the chick it has been shown that the level of cell proliferation within the limb bud must be precisely specified to in order to result in sufficient antero-posterior expansion to form the correct digit number <xref rid="pgen.1002114-Towers1" ref-type="bibr">[48]</xref>. If a similar mechanism exists in vertebrates then it may be that <italic>SMOC1/Smoc1</italic> mutations could cause oligodactyly by altering the BMP gradient within the limb bud and thus alter anteroposterior expansion. Although the molecular basis of the developmental pathology associated with OAS remains to be elucidated, support for SMOC-1 mediated BMP antagonism as a component is provided by human and mouse genetic data that indicate the importance of BMP signalling in both limb <xref rid="pgen.1002114-Maatouk1" ref-type="bibr">[56]</xref>, <xref rid="pgen.1002114-PajniUnderwood1" ref-type="bibr">[57]</xref> and eye <xref rid="pgen.1002114-Bakrania1" ref-type="bibr">[8]</xref>, <xref rid="pgen.1002114-Chang1" ref-type="bibr">[58]</xref>, <xref rid="pgen.1002114-Furuta1" ref-type="bibr">[59]</xref> development. Interestingly, heterozygous <italic>BMP4</italic> mutations have been associated with microphthalmia, microcornea, coloboma, retinal dystrophy, and tilted optic disc <xref rid="pgen.1002114-Bakrania1" ref-type="bibr">[8]</xref>. In addition, <italic>BMP4</italic> mutations are also associated with digital anomalies (polydactyly) and cleft lip/palate <xref rid="pgen.1002114-Suzuki1" ref-type="bibr">[60]</xref>. The partial overlap between the OAS phenotype and the phenotypes associated with BMP4 disruptions may reflect a functional relationship between SMOC-1 and BMP4.</p>
      <p>Following submission of this paper two other groups have identified <italic>SMOC1</italic> mutations as a cause of OAS <xref rid="pgen.1002114-Abouzeid1" ref-type="bibr">[10]</xref>, <xref rid="pgen.1002114-Okada1" ref-type="bibr">[61]</xref>. One group studied five affected individuals from four unrelated OAS families <xref rid="pgen.1002114-Okada1" ref-type="bibr">[61]</xref>. They identified the locus on 14q24 and then found <italic>SMOC1</italic> mutations in three out of four of the families. Interestingly these were the same families in whom linkage to 10p11.23 had been previously reported by the same group <xref rid="pgen.1002114-Hamanoue1" ref-type="bibr">[17]</xref>. The <italic>SMOC1</italic> mutations were all homozygous and plausibly loss of function (one nonsense and two 5â² splice site mutations). This group also reported the phenotype in homozygous mice with Sleeping beauty transposon-induced gene trap mutations of <italic>Smoc1</italic>. The expression analysis and limb phenotype of the mice are very similar to that reported here. Their homozygous mice also showed unexplained uniform early lethality. Interestingly their mice had small eyes but they do not report coloboma. The optic nerves were shown to be significantly narrower than non-homozygous animals and they also showed extension of the RPE into the optic nerve. The second paper reports linkage to 14q24 and identification of a 5â² splice site mutation in <italic>SMOC1</italic> in a single multiplex family with OAS <xref rid="pgen.1002114-Abouzeid1" ref-type="bibr">[10]</xref>. This group also reports developmental expression analysis of the orthologous gene, <italic>smoc1</italic>, in zebrafish embryos. Expression was evident in the brain, choroid fissure and pharyngeal arches. âKnock-downâ experiments using a morpholino targeted to <italic>smoc1</italic> resulted in microphthalmia and brain abnormalities in the injected embryos. Taken together these papers strongly support loss of SMOC-1 function as the major cause of OAS and that this protein has a conserved non-redundant function during ocular and limb development.</p>
      <p>Finally, in six families with typical OAS we could not identify <italic>SMOC1</italic> mutations, including the original family described by Waardenburg in 1935 <xref rid="pgen.1002114-Waardenburg1" ref-type="bibr">[9]</xref>. In two of these six families, affected individuals show homozygosity over the region of 14q24.2 suggesting that we have significant limitations in our current <italic>SMOC1</italic> mutation analysis strategy. However, four families showed no apparent autozygosity around <italic>SMOC1,</italic> suggesting the likely existence of other OAS loci. Identifying causative genes at other loci is likely to help elucidate the embryopathology and is an active area of our future work.</p>
    </sec>
    <sec sec-type="materials|methods" id="s4">
      <title>Materials and Methods</title>
      <sec id="s4a">
        <title>Patient Recruitment and Ethics Approval</title>
        <p>All patient related work was carried out with full written consent of the families. Details of the mutation positive cases are provided in <xref ref-type="table" rid="pgen-1002114-t001">Table 1</xref>. The informed consent process was reviewed and approved following consideration by national ethical committee systems in the UK and the Netherlands. Several of the cases have been previously published. <xref rid="pgen.1002114-Garavelli1" ref-type="bibr">[16]</xref>, <xref rid="pgen.1002114-Khan1" ref-type="bibr">[19]</xref>, <xref rid="pgen.1002114-Pallotta1" ref-type="bibr">[22]</xref>, <xref rid="pgen.1002114-Sayli1" ref-type="bibr">[25]</xref>, <xref rid="pgen.1002114-Suyugul1" ref-type="bibr">[26]</xref>
</p>
      </sec>
      <sec id="s4b">
        <title>Mapping and Linkage Analysis</title>
        <p>Patient, parental and unaffected sib genomic DNA samples were run on Affymetrix GeneChip Human Mapping 10K Arrays (Xba131) and autozygosity mapping was performed using ExludeAR 1 with data subjected to multipoint linkage analysis using ALOHOMORA and Allegro (V1.2c). Gene data in the candidate interval were retrieved from the Ensembl Human genome (GRCh37 assembly; <ext-link ext-link-type="uri" xlink:href="http://www.ensembl.org/Homo_sapiens/index.html">http://www.ensembl.org/Homo_sapiens/index.html</ext-link>). Microsatellites containing tri- or tetranucleotide repeats (<xref ref-type="table" rid="pgen-1002114-t003">Table 3</xref>) were identified from the UCSC browser (<ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu/index.html">http://genome.ucsc.edu/index.html</ext-link>) and PCR primers were designed using Primer3 (<ext-link ext-link-type="uri" xlink:href="http://frodo.wi.mit.edu/primer3/">http://frodo.wi.mit.edu/primer3/</ext-link>). FAM fluorescent labels were placed at the 5â²-end of the forward primer. All microsatellites were tested for informativeness for each family.</p>
        <table-wrap id="pgen-1002114-t003" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pgen.1002114.t003</object-id>
          <label>Table 3</label>
          <caption>
            <title>Microsatellite repeat marker PCR and primer properties.</title>
          </caption>
          <alternatives>
            <graphic id="pgen-1002114-t003-3" xlink:href="pgen.1002114.t003"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Microsatellite (Chr14: bp)</td>
                  <td align="left" rowspan="1" colspan="1">Forward primer</td>
                  <td align="left" rowspan="1" colspan="1">Reverse primer</td>
                  <td align="left" rowspan="1" colspan="1">Approx size (Repeat type)</td>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" rowspan="1" colspan="1">D14S6790 (67906158â67906384)</td>
                  <td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">CTGACAATTTGGGGAAAAGG</named-content>
</td>
                  <td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">GGTACTGCTCTGAGGTCTGGA</named-content>
</td>
                  <td align="left" rowspan="1" colspan="1">320 bp (tetra)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">D14S6889 (68892553â68892831)</td>
                  <td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">TCTGGAGGACTCAGAAGAAGAGA</named-content>
</td>
                  <td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">CCCAGGCAACAAGAGTGAA</named-content>
</td>
                  <td align="left" rowspan="1" colspan="1">300 bp (tetra)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">D14S6921 (69216842â69217056)</td>
                  <td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">CAGCTACTTCCACCGTCTCC</named-content>
</td>
                  <td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACACTTGGTGCCCTTGAAAC</named-content>
</td>
                  <td align="left" rowspan="1" colspan="1">200 bp (tetra)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">D14S6974 (69749225â69749449)</td>
                  <td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">CGCCCTTGGAAATGATTTTT</named-content>
</td>
                  <td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">GATAGCACCACTGCACTCCA</named-content>
</td>
                  <td align="left" rowspan="1" colspan="1">250 bp (tetra)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">D14S258 (70583011â70583186)</td>
                  <td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">TCACTGCATCTGGAAGCAC</named-content>
</td>
                  <td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">CTAACTAAATGGCGAGCATTGAG</named-content>
</td>
                  <td align="left" rowspan="1" colspan="1">170 bp (di)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">D14S6985 (70786661â70786943)</td>
                  <td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">CTCCATGAAACACCCAGTCC</named-content>
</td>
                  <td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">GGCAGAAAAATCGCTTGAAC</named-content>
</td>
                  <td align="left" rowspan="1" colspan="1">285 bp (tetra)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">D14S7023 (71168266â71168625)</td>
                  <td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">AGGGGTTAGCGAGAAGGAAG</named-content>
</td>
                  <td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">GCAGGTAGAGGATGCCAGAG</named-content>
</td>
                  <td align="left" rowspan="1" colspan="1">330 bp (tri)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">D14S7033 (71259290â71260458)</td>
                  <td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">TGAGCCCAGGAGTTCAAGAC</named-content>
</td>
                  <td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">AGCTCCCAGCATAGTTCCAG</named-content>
</td>
                  <td align="left" rowspan="1" colspan="1">270 bp (tetra)</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
        </table-wrap>
      </sec>
      <sec id="s4c">
        <title>PCR and Sequence Analysis</title>
        <p>Genomic DNA samples were Whole Genome Amplified (WGA) using the Illustra GenomiPhi V2 DNA Amplification Kit (GE Healthcare) according to the manufacturer's guidelines. For PCR, 50 ng WGA template DNA was amplified with 0.2 ÂµM primers and 2x Custom Reddymix (Thermo Scientific) in H<sub>2</sub>O to 25 Âµl. Cycle conditions: 95Â°CÃ3 minutes; and 35Ãcycles of 95Â°CÃ1 minute, 56Â°CÃ45 seconds, and 72Â°CÃ1 minute; followed by a single step of 72Â°CÃ10 minutes. All mutations were confirmed by resequencing using non-WGA genomic DNA with identical reaction conditions. Sequencing was performed using Applied Biosystems 3130/3170 Genetic Analysers. Genbank sequences were downloaded from NCBI build 37.2 and mutation analysis was performed with Mutation Surveyor Software (SoftGenetics LLC, PA, USA) or Sequencher 4.8 (GeneCodes Corp. MI, USA).</p>
      </sec>
      <sec id="s4d">
        <title>In Situ Hybridisations</title>
        <p>To generate a DNA tempate for production of <italic>Smoc1</italic> riboprobe, PCR was performed from mouse genomic DNA targeting the 3â² untranslated region (UTR) of the <italic>Smoc1</italic> gene using primers with T3 and T7 RNA polymerase sites at the 5â² ends of the forward and reverse primers respectively (underlined) (<italic>Smoc1</italic> Forward <named-content content-type="gene">5â²- <underline>AATTAACCCTCACTAAAGG</underline>CGTGTGTGGTTTGTTTCTGG-3â²</named-content>; <italic>Smoc1</italic> Reverse <named-content content-type="gene">5â²- <underline>TAATACGACTCACTATAGG</underline>TAGACTGCCAAGGGATCTGG-3â²</named-content>). Digoxigenin (DIG) labelled (Roche) sense and antisense riboprobes were generated by <italic>in vitro</italic> transcription using T3 and T7 RNA polymerase respectively. Whole-mount in situ hybridization to mouse embryos at 9.5 &amp; 10.5 days post-coitum (dpc or E9.5/E10.5) was carried out as previously described <xref rid="pgen.1002114-Harewood1" ref-type="bibr">[62]</xref>. Briefly embryos were fixed overnight in 4% paraformaldehyde (PFA) at 4Â°C, proteinase K (10 Âµg/ml) (Roche) treated for 15â35 minutes, depending on the stage then washed twice in 0.1 M triethanolamine, washed in phosphate-buffered saline (PBS) -Tween (0.1%) and refixed in 4% PFA/0.2% glutaraldehyde for 20 minutes. Prehybridisation was performed for 2 hours and hybridisation for 40 hours at 60Â°C in hybridisation buffer containing each DIG labelled probe. Washes were in 2Ãhybridisation buffer for 10 minutes, 3Ã2ÃSSC +0.1% Tween 20 for 20 minutes, 3Ã0.2ÃSSC +0.1% Tween 20 for 30 minutes, all at 60Â°C. At room temperature the embryos were washed in 1 M Malic Acid with 2% BMB (Boehringer- Mannheim blocking reagent) +20% heat-treated lamb serum solution for 2 hours and then in the same buffer containing a 1/2000 dilution of anti-DIG antibody coupled to alkaline phosphatase (Roche) overnight at 4Â°C. Embryos were washed 3Ã5 minutes and 3Ã1 hour in MAB. Colour detection was performed in 2 ml of BM purple precipitating solution (Roche).</p>
      </sec>
      <sec id="s4e">
        <title>
<italic>Smoc1</italic> Targeted Mouse</title>
        <p>The <italic>Smoc1</italic> pre-conditional knockout mouse (EUCOMM Project 48154; strain C57BL/6N-A-Smoc1<sup>tm1a(EUCOMM)WTSI</sup>, referred to as <italic>Smoc1<sup>tm1a</sup></italic> in this manuscript) was generated by the International knockout Mouse Consortium (IKMC) under UK Home Office Project License 60/3785 (IJ Jackson, MRC Human Genetics Unit). Details of the allele and targeting strategy can be found at: <ext-link ext-link-type="uri" xlink:href="http://www.eucomm.org/htgt/report/gene_report?project_id=48154">http://www.eucomm.org/htgt/report/gene_report?project_id=48154</ext-link> and in <xref ref-type="supplementary-material" rid="pgen.1002114.s001">Figure S1</xref>. Genotypes were confirmed using the <italic>Smoc1</italic> forward primer 5â²-GGTCTGACTCGGTAGGCTTG- 3â² (positioned at mChr12â¶82,236,250 bp) and <italic>Smoc1</italic> reverse primer <named-content content-type="gene">5â²-CCTCTCTCCAACCCTTTTCC-3â²</named-content> (positioned at mChr12â¶82,236,907 bp) which flank the targeted endogenous exon and produce a wild type PCR amplicon of 658 bp. Adding the targeting cassette specific primer <named-content content-type="gene">5â²- TTAGTCCCAACCCCTTCCTC-3â²</named-content> to PCR mixes as multiplex reactions produced a targeted-allele specific amplicon of 250 bp. Ear-clip DNA was extracted by incubating in 50 Âµl of 25 mM NaOH 0.2 mM EDTA solution at 95oC for 1 hour, then adding 50 Âµl of 40 mM Trizma. 1 Âµl of template was used for PCR reactions with 0.2 ÂµM primers and 2x Custom Reddymix (Thermo Scientific) in H<sub>2</sub>O to 50 Âµl. Cycle conditions: 95Â°CÃ3 minutes; and 31Ãcycles of 95Â°CÃ45 seconds, 56Â°CÃ40 seconds, and 72Â°CÃ1 minute; followed by a single step of 72Â°CÃ10 minutes. Products were run on 1% TBE agarose gels. For qRT-PCR, mouse hind limbs at stage 10.5 dpc were dissected and mRNA extracted using TRIzol (Invitrogen) according to the manufacturers instructions. Mice were genotyped by PCR using genomic DNA as described above with WT and <italic>Smoc1<sup>tm1a/tm1a</sup></italic> samples carried on for testing. Samples were DNaseI treated and then cycled using Power SYBR Green RNA-to-CT 1-Step Kit (Applied Biosystems) using an ABI-HT7900 SDS instrument (Applied Biosystems) with the following conditions: 48Â°CÃ30 minutes, 95Â°CÃ10 minutes, followed by 40 cycles of 95Â°CÃ15 seconds and 60Â°CÃ1 minute. Each 10 Âµl reaction contained 0.08 Âµl of RT Enzyme Mix; 5 Âµl of RT-PCR Mix; 1 Âµl RNA sample and 1.92 Âµl sdH<sub>2</sub>O, with the inclusion of either <italic>Smoc1</italic> forward <named-content content-type="gene">5â²-GGATGGTTCCTTCACACAGG-3â²</named-content> and reverse <named-content content-type="gene">5â²- TCATCTCCATCGAACACAGG-3â²</named-content> primers or <italic>Hprt</italic> forward <named-content content-type="gene">5â²- CTGGTGAAAAGGACCTCTCG -3â²</named-content> and reverse <named-content content-type="gene">5â²- CAAGGGCATATCCAACAACA-3â²</named-content> primers. Each reaction was performed in triplicate in optical reaction plates (384-well, Applied Biosystems), and RNA samples were also run without RT Enzyme Mix for negative controls with the same reaction conditions.</p>
      </sec>
      <sec id="s4f">
        <title>Histological and Histochemical Analysis</title>
        <p>Embryos were fixed in 4% PFA; dehydrated through graded alcohol series and xylene; and embedded in paraffin. Microtome sections were cut at 6 Âµm and rehydrated through ethanol series and stained with haematoxylin and eosin. For skeletal preparations the animals were dehydrated in 95% ethanol for 24 hours; followed by 72 hours in 100% acetone; 3 days in stain solution (1 part 0.3% alcian blue in 70% ethanol; 1 part 0.1% alazarin red in 95% ethanol; and 1 part acetic acid, in 17 parts 70% ethanol); followed by 3 days clearing in 1% KOH; 3 days in 1% KOH/30% glycerol; and two 24 hour periods in 1% KOH/50% glycerol; in 1% KOH/70% glycerol and were analysed in 100% glycerol. X-gal (5-bromo-4-chloro-3-indolyl-Î²-D- galactopyranoside) staining was performed as follows: targeted mouse embryos were dissected at 10.5 dpc and rinsed in PBS, then fixed for 1 hour in 4% PFA at 4oC, rinsed again in PBS and then washed for 3x 20 minutes in detergent wash (2 mM MgCl<sub>2</sub>, 0.1% Sodium Deoxycholate, 0.02% NP-40 [Igepal CA 630], in PBS). Detection was performed in Î²-galactosidase stain (0.085% NaCl, 5 mM K3 [Fe(CN)6], 5 mM K4 [Fe(CN)6], 200 Âµl/ml X-gal (Promega), in detergent wash), followed by a brief final stain fixation in 4% PFA for 30 minutes. For cryosection analysis, embryos were dissected and fixed as above, then incubated overnight in 20% sucrose/PBS at 4Â°C, transferred into OCT solution and frozen embedded on dry ice. Sections of 25 Âµm thickness were cut at â20Â°C, air dried and rinsed briefly in PBS. X-gal staining was then performed as described above.</p>
      </sec>
      <sec id="s4g">
        <title>Optical Projection Tomography</title>
        <p>For optical projection tomography (OPT) analysis <italic>In Situ</italic> stained embryos were mounted in 1% agarose, dehydrated in methanol and then cleared overnight in BABB solution (1 part Benzyl Alcohol: 2 parts Benzyl Benzoate). Samples were then imaged using a Bioptonics OPT Scanner 3001 (Bioptonics, UK) using brightfield analysis to detect tissue autofluorescence for capture of anatomical and signal data (wavelengths: excitation at 425 nm, emission: 475 nm). The resulting data were reconstructed using Bioptonics proprietary software (Bioptonics, MRC Technology, Edinburgh, UK), then automatically thresholded to remove background and finally merged into a single 3D image output using Bioptonics Viewer software.</p>
      </sec>
    </sec>
    <sec sec-type="supplementary-material" id="s5">
      <title>Supporting Information</title>
      <supplementary-material content-type="local-data" id="pgen.1002114.s001">
        <label>Figure S1</label>
        <caption>
          <p>Expression of Smoc1 in the limb buds and eye, and phenotype in Smoc1<sup>tm1a/tm1a</sup> limbs. (aâc) Magnified images and digital section of the same OPT reconstruction of a wild-type E10.5 embryo shown in <xref ref-type="fig" rid="pgen-1002114-g002">Figure 2</xref> with green staining representing <italic>Smoc1</italic> expression. (a) <italic>Smoc1</italic> expression is seen in both the dorsal and ventral surface of the forelimb buds. (b) In the hindlimb expression is predominantly dorsal and with small region of ventral expression. (c) Digital section showing symmetrical low-level expression of <italic>Smoc1</italic> in the surface ectoderm overlying the optic vesicles (OV). (d) Diagram illustrating the gene targeting for the EUCOMM pre-conditional <italic>Smoc1</italic> knockout mouse at the genomic level (top) with the relative positions of RT-PCR primers indicated. Targeting cassette (bottom) is specific for exon 4 of <italic>Smoc1</italic>. Positions of genotyping PCR primers are indicated (GT-F &amp; -R2, blue, are endogenous-gene specific, GT-R1 is cassette-specific) Note that the targeting cassette has the Î²-galactosidase ORF inserted downstream of an EN2 splice acceptor site (EN2 SA) and internal ribosomal entry site (IRES), allowing for reporter expression in successfully <italic>Smoc1</italic>-targeted animals (pA is Poly(A) tail). The cassette also features FRT and Cre-recombinase (loxP) sequences for future gene manipulation. Ensembl exon identifiers are given. A table of the phenotypes associated with the targeted allele is available in <xref ref-type="table" rid="pgen-1002114-t002">Table 2</xref> of the main manuscript. (e) Agarose gel indicating each allele identified by genotyping PCR primers. Aâ=âphenotypically wild type animal, Bâ=âlittermate with hindlimb oligodactyly, Wtâ=âwild type unrelated mouse DNA sample. Primer pair 1 (GT-F &amp; GT-R2) amplified wild type allele only, Primer pair 2 (GT-F &amp; GT-R1) amplified the targeted allele only, multiplex reaction (GT-F &amp; GT-R2 &amp; GT-R1) identified both WT and mutant alleles and revealed animal B as a <italic>Smoc1</italic> homozygote (<italic>Smoc1<sup>tm1a/tm1a</sup></italic>) and A as a heterozygote (<italic>Smoc1<sup>+/tm1a</sup></italic>). Multiplex reactions were then used as standard for genotyping <italic>Smoc1</italic> status in analysed animals. (f) Quantitative RT-PCR analysis of dissected hindlimb tissue from E10.5 wild type and homozygote animals revealed significant reduction of Wt <italic>Smoc1</italic> mRNA in mutant animals (WT, nâ=â2; <italic>Smoc1<sup>tm1a/tm1a</sup></italic>, nâ=â4). (g) Skeletal preparation of P0 <italic>Smoc1<sup>tm1a/tm1a</sup></italic> hindlimb showing absent fibula (arrow) (T- tibia; F-femur).</p>
          <p>(TIF)</p>
        </caption>
        <media xlink:href="pgen.1002114.s001.tif">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pgen.1002114.s002">
        <label>Figure S2</label>
        <caption>
          <p>Phenotypic analysis and X-gal staining of <italic>Smoc1</italic> mutant animals. (a &amp; b) Low power magnification of H&amp;E stained eyes revealed that mutant eyes were grossly normal but that overall eye size was reduced. (c &amp; d) Higher magnification analysis revealed normal organization and retinal cell-layer lamination in <italic>Smoc1<sup>tm1a/tm1a</sup></italic> mutant eyes. Abbreviations: c, cornea; ln, lens; r, retina; gcl, ganglion cell layer; inl, inner nuclear layer; onl, outer nuclear layer; rpe, retinal pigmented epithelium (Scale bars: a &amp; bâ=â250 Âµm; c, d &amp; eâ=â100 Âµm). (e) Maximum width measurements were taken for optic nerves (on) of <italic>Smoc1<sup>tm1a/tm1a</sup></italic> mutants (<italic>nâ=â17</italic>) and controls (<italic>nâ=â11</italic>) from paraffin-embedded sections (f) This plot shows the significantly smaller mean diameter of the optic nerve in mutants compared to control animals with the error bars representing the non-overlapping of 95% confidence limits; 125.7 Âµm (118.2â133.3) and 147.0 Âµm (139.6â154.5) respectively. (g,h) Transverse digital sections from OPT scans of E14.5 WT and <italic>Smoc1<sup>tm1a/tm1a</sup></italic> embryos showing an apparently normal size and shape of developing kidneys (arrows). Scale barâ=â1 mm. (i) Whole mount X-gal stained <italic>Smoc1<sup>tm1a/tm1a</sup></italic> embryo at E14.5. This embryo was dissected to reveal the developing kidneys. No X-gal positive cells can be seen in the kidneys (LK, left kidney; RK, right kidney) or bladder (B). Stain is clearly seen in both adrenal glands (arrowheads) and in tissue adjacent to the developing vertebrae (V). Scale barâ=â500 Âµm. (j) Sagittal cryosection of 25 Âµm thickness counterstained with eosin showing strong X-gal staining in the tissue between the developing vertebral bodies (VB). (k) E14.5 stage left kidney seen in i. No stain positive cells can be seen within the kidney (KID) but a cluster of positively staining cells are seen within the adrenal (ADR). Scale barâ=â100 Âµm.</p>
          <p>(TIF)</p>
        </caption>
        <media xlink:href="pgen.1002114.s002.tif">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pgen.1002114.s003">
        <label>Figure S3</label>
        <caption>
          <p>Alignment of human SMOC-1 Thyroglobulin type-1 (Tg1) domains with Tg1 domains from mouse Smoc-1, Xenopus tropicalis Smoc-1 and Drosophila melanogaster Pentagone. Alignment of the Tg1-1 and Tg1-2 domains from mouse Smoc-1 and human SMOC-1 with the Tg1-2 domains from <italic>Xenopus tropicalis</italic> Smoc-1 and <italic>Drosophila melanogaster</italic> Pentagone. The position of identical amino acid residues across all sequences is given by pink shading. The gray shading indicates the conservation of the positions in the Tg1-2 affected by the missense mutations and the nature and position of the mutations is shown in red text below. Key: Tg1â=âThyroglobulin type-1 domain; Tg1-1â=âfirst Tg1 in the peptide; Tg1-2â=âsecond Tg1 in the peptide; hSMOC1â=âhuman SMOC1; mSmoc1â=âmouse Smoc1; xtSmoc1â=â<italic>Xenopus tropicalis</italic> Smoc1; dmPentâ=â<italic>Drospophila melanogaster</italic> Pentagone protein; Q9h4F8 etc are UniProt accession numbers.</p>
          <p>(DOC)</p>
        </caption>
        <media xlink:href="pgen.1002114.s003.doc">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pgen.1002114.s004">
        <label>Video S1</label>
        <caption>
          <p>OPT analysis of <italic>Smoc1</italic> expression in wild-type E9.5 mouse embryo.</p>
          <p>(MPG)</p>
        </caption>
        <media xlink:href="pgen.1002114.s004.mpg">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pgen.1002114.s005">
        <label>Video S2</label>
        <caption>
          <p>OPT analysis of <italic>Smoc1</italic> expression in wild-type E10.5 mouse embryo.</p>
          <p>(MPG)</p>
        </caption>
        <media xlink:href="pgen.1002114.s005.mpg">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pgen.1002114.s006">
        <label>Dataset S1</label>
        <caption>
          <p>UCSC custom track for the hg18 genome build that represents the distribution of homozygous regions in the individuals affected with Ophthalmo-acromelic syndrome in our study. The homozygous regions are defined as the genomic coordinates encompassing 20 contiguous homozygous genotypic calls. The regions surrounding SMOC1 shows the multiple overlapping homozygous regions in unrelated families and provides a graphical representation of the linkage of OAS to this region of chromosome 14.</p>
          <p>(TXT)</p>
        </caption>
        <media xlink:href="pgen.1002114.s006.txt">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack>
      <p>We would like to express our thanks to the children and their families who gave their time and biological samples to make this research possible. We thank Drs Dariusz Michna and Cesare Rossi for help with Family 1 and Family 2 respectively. Dr. Nurten Arkarsu generously contributed genetic and clinical information on Family 7. We also acknowledge the help with sequencing from MRC HGU Technical Support.</p>
    </ack>
    <fn-group>
      <fn fn-type="COI-statement">
        <p>The authors have declared that no competing interests exist.</p>
      </fn>
      <fn fn-type="financial-disclosure">
        <p>Funding for this project was provided as an intramural program grant from the Medical Research Council (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="pgen.1002114-Morrison1">
        <label>1</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Morrison</surname><given-names>D</given-names></name><name><surname>FitzPatrick</surname><given-names>D</given-names></name><name><surname>Hanson</surname><given-names>I</given-names></name><name><surname>Williamson</surname><given-names>K</given-names></name><name><surname>van Heyningen</surname><given-names>V</given-names></name><etal/></person-group>
<year>2002</year>
<article-title>National study of microphthalmia, anophthalmia, and coloboma (MAC) in Scotland: investigation of genetic aetiology.</article-title>
<source>J Med Genet</source>
<volume>39</volume>
<fpage>16</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="pmid">11826019</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Fantes1">
        <label>2</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fantes</surname><given-names>J</given-names></name><name><surname>Ragge</surname><given-names>NK</given-names></name><name><surname>Lynch</surname><given-names>SA</given-names></name><name><surname>McGill</surname><given-names>NI</given-names></name><name><surname>Collin</surname><given-names>JR</given-names></name><etal/></person-group>
<year>2003</year>
<article-title>Mutations in SOX2 cause anophthalmia.</article-title>
<source>Nat Genet</source>
<volume>33</volume>
<fpage>461</fpage>
<lpage>463</lpage>
<pub-id pub-id-type="pmid">12612584</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Ragge1">
        <label>3</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ragge</surname><given-names>NK</given-names></name><name><surname>Lorenz</surname><given-names>B</given-names></name><name><surname>Schneider</surname><given-names>A</given-names></name><name><surname>Bushby</surname><given-names>K</given-names></name><name><surname>de Sanctis</surname><given-names>L</given-names></name><etal/></person-group>
<year>2005</year>
<article-title>SOX2 anophthalmia syndrome.</article-title>
<source>Am J Med Genet A</source>
<volume>135</volume>
<fpage>1</fpage>
<lpage>7</lpage>
<comment>discussion 8</comment>
<pub-id pub-id-type="pmid">15812812</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Williamson1">
        <label>4</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Williamson</surname><given-names>KA</given-names></name><name><surname>Hever</surname><given-names>AM</given-names></name><name><surname>Rainger</surname><given-names>J</given-names></name><name><surname>Rogers</surname><given-names>RC</given-names></name><name><surname>Magee</surname><given-names>A</given-names></name><etal/></person-group>
<year>2006</year>
<article-title>Mutations in SOX2 cause anophthalmia-esophageal-genital (AEG) syndrome.</article-title>
<source>Hum Mol Genet</source>
<volume>15</volume>
<fpage>1413</fpage>
<lpage>1422</lpage>
<pub-id pub-id-type="pmid">16543359</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Ragge2">
        <label>5</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ragge</surname><given-names>NK</given-names></name><name><surname>Brown</surname><given-names>AG</given-names></name><name><surname>Poloschek</surname><given-names>CM</given-names></name><name><surname>Lorenz</surname><given-names>B</given-names></name><name><surname>Henderson</surname><given-names>RA</given-names></name><etal/></person-group>
<year>2005</year>
<article-title>Heterozygous mutations of OTX2 cause severe ocular malformations.</article-title>
<source>Am J Hum Genet</source>
<volume>76</volume>
<fpage>1008</fpage>
<lpage>1022</lpage>
<pub-id pub-id-type="pmid">15846561</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Henderson1">
        <label>6</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Henderson</surname><given-names>RH</given-names></name><name><surname>Williamson</surname><given-names>KA</given-names></name><name><surname>Kennedy</surname><given-names>JS</given-names></name><name><surname>Webster</surname><given-names>AR</given-names></name><name><surname>Holder</surname><given-names>GE</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>A rare de novo nonsense mutation in OTX2 causes early onset retinal dystrophy and pituitary dysfunction.</article-title>
<source>Mol Vis</source>
<volume>15</volume>
<fpage>2442</fpage>
<lpage>2447</lpage>
<pub-id pub-id-type="pmid">19956411</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Pasutto1">
        <label>7</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pasutto</surname><given-names>F</given-names></name><name><surname>Sticht</surname><given-names>H</given-names></name><name><surname>Hammersen</surname><given-names>G</given-names></name><name><surname>Gillessen-Kaesbach</surname><given-names>G</given-names></name><name><surname>Fitzpatrick</surname><given-names>DR</given-names></name><etal/></person-group>
<year>2007</year>
<article-title>Mutations in STRA6 cause a broad spectrum of malformations including anophthalmia, congenital heart defects, diaphragmatic hernia, alveolar capillary dysplasia, lung hypoplasia, and mental retardation.</article-title>
<source>Am J Hum Genet</source>
<volume>80</volume>
<fpage>550</fpage>
<lpage>560</lpage>
<pub-id pub-id-type="pmid">17273977</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Bakrania1">
        <label>8</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bakrania</surname><given-names>P</given-names></name><name><surname>Efthymiou</surname><given-names>M</given-names></name><name><surname>Klein</surname><given-names>JC</given-names></name><name><surname>Salt</surname><given-names>A</given-names></name><name><surname>Bunyan</surname><given-names>DJ</given-names></name><etal/></person-group>
<year>2008</year>
<article-title>Mutations in BMP4 cause eye, brain, and digit developmental anomalies: overlap between the BMP4 and hedgehog signaling pathways.</article-title>
<source>Am J Hum Genet</source>
<volume>82</volume>
<fpage>304</fpage>
<lpage>319</lpage>
<pub-id pub-id-type="pmid">18252212</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Waardenburg1">
        <label>9</label>
        <element-citation publication-type="other">
<person-group person-group-type="author"><name><surname>Waardenburg</surname><given-names>PJ</given-names></name></person-group>
<year>1961</year>
<article-title>Autosomally-recessive anophthalmia with malformations of the hands and feet.</article-title>
<person-group person-group-type="editor"><name><surname>P. J. Waardenburg</surname><given-names>AFaDK</given-names></name></person-group>
<source>Vol I. Assen, The Netherlands: Royal Van Gorcum</source>
<size units="page">773</size>
</element-citation>
      </ref>
      <ref id="pgen.1002114-Abouzeid1">
        <label>10</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Abouzeid</surname><given-names>H</given-names></name><name><surname>Boisset</surname><given-names>G</given-names></name><name><surname>Favez</surname><given-names>T</given-names></name><name><surname>Youssef</surname><given-names>M</given-names></name><name><surname>Marzouk</surname><given-names>I</given-names></name><etal/></person-group>
<year>2011</year>
<article-title>Mutations in the SPARC-related modular calcium-binding protein 1 gene, SMOC1, cause waardenburg anophthalmia syndrome.</article-title>
<source>Am J Hum Genet</source>
<volume>88</volume>
<fpage>92</fpage>
<lpage>98</lpage>
<pub-id pub-id-type="pmid">21194680</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-LI1">
        <label>11</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>LI</surname><given-names>AG</given-names></name><name><surname>Sabarinathan DK A</surname><given-names>K</given-names></name></person-group>
<year>1994</year>
<article-title>Microphthalmia and distal limb abnormalities in a child of consanguineous parents.</article-title>
<source>Clin Dysmorphol</source>
<volume>3</volume>
<fpage>258</fpage>
<lpage>262</lpage>
<pub-id pub-id-type="pmid">7981863</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Caksen1">
        <label>12</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Caksen</surname><given-names>H</given-names></name><name><surname>Odabas</surname><given-names>D</given-names></name><name><surname>Oner</surname><given-names>AF</given-names></name><name><surname>Abuhandan</surname><given-names>M</given-names></name><name><surname>Calebi</surname><given-names>V</given-names></name></person-group>
<year>2002</year>
<article-title>Ophthalmo-acromelic syndrome in a Turkish infant: case report.</article-title>
<source>East Afr Med J</source>
<volume>79</volume>
<fpage>339</fpage>
<lpage>340</lpage>
<pub-id pub-id-type="pmid">12643234</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Cogulu1">
        <label>13</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cogulu</surname><given-names>O</given-names></name><name><surname>Ozkinay</surname><given-names>F</given-names></name><name><surname>Gunduz</surname><given-names>C</given-names></name><name><surname>Sapmaz</surname><given-names>G</given-names></name><name><surname>Ozkinay</surname><given-names>C</given-names></name></person-group>
<year>2000</year>
<article-title>Waardenburg anophthalmia syndrome: report and review.</article-title>
<source>Am J Med Genet</source>
<volume>90</volume>
<fpage>173</fpage>
<lpage>174</lpage>
<pub-id pub-id-type="pmid">10607960</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Galasso1">
        <label>14</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Galasso</surname><given-names>C</given-names></name><name><surname>Bombardieri</surname><given-names>R</given-names></name><name><surname>Cerminara</surname><given-names>C</given-names></name><name><surname>Stranci</surname><given-names>G</given-names></name><name><surname>Curatolo</surname><given-names>P</given-names></name></person-group>
<year>2007</year>
<article-title>Anophthalmia-Waardenburg syndrome with expanding phenotype: does neural crest play a role?</article-title>
<source>J Child Neurol</source>
<volume>22</volume>
<fpage>1252</fpage>
<lpage>1255</lpage>
<pub-id pub-id-type="pmid">18006952</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Gambhir1">
        <label>15</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gambhir</surname><given-names>PS</given-names></name><name><surname>Gambhir</surname><given-names>SP</given-names></name><name><surname>Bankar</surname><given-names>SM</given-names></name></person-group>
<year>2010</year>
<article-title>Ophthalmoacromelic syndrome: two further cases expanding the phenotype.</article-title>
<source>Clin Dysmorphol</source>
<volume>19</volume>
<fpage>91</fpage>
<lpage>94</lpage>
<pub-id pub-id-type="pmid">20179580</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Garavelli1">
        <label>16</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Garavelli</surname><given-names>L</given-names></name><name><surname>Pedori</surname><given-names>S</given-names></name><name><surname>Dal Zotto</surname><given-names>R</given-names></name><name><surname>Franchi</surname><given-names>F</given-names></name><name><surname>Marinelli</surname><given-names>M</given-names></name><etal/></person-group>
<year>2006</year>
<article-title>Anophthalmos with limb anomalies (Waardenburg opththalmo-acromelic syndrome): report of a new Italian case with renal anomaly and review.</article-title>
<source>Genet Couns</source>
<volume>17</volume>
<fpage>449</fpage>
<lpage>455</lpage>
<pub-id pub-id-type="pmid">17375532</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Hamanoue1">
        <label>17</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hamanoue</surname><given-names>H</given-names></name><name><surname>Megarbane</surname><given-names>A</given-names></name><name><surname>Tohma</surname><given-names>T</given-names></name><name><surname>Nishimura</surname><given-names>A</given-names></name><name><surname>Mizuguchi</surname><given-names>T</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>A locus for ophthalmo-acromelic syndrome mapped to 10p11.23.</article-title>
<source>Am J Med Genet A</source>
<volume>149A</volume>
<fpage>336</fpage>
<lpage>342</lpage>
<pub-id pub-id-type="pmid">19208380</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Kara1">
        <label>18</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kara</surname><given-names>F</given-names></name><name><surname>Yesildaglar</surname><given-names>N</given-names></name><name><surname>Tuncer</surname><given-names>RA</given-names></name><name><surname>Semerci</surname><given-names>N</given-names></name><name><surname>Onat</surname><given-names>N</given-names></name><etal/></person-group>
<year>2002</year>
<article-title>A case report of prenatally diagnosed ophthalmo-acromelic syndrome type Waardenburg.</article-title>
<source>Prenat Diagn</source>
<volume>22</volume>
<fpage>395</fpage>
<lpage>397</lpage>
<pub-id pub-id-type="pmid">12001194</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Khan1">
        <label>19</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Khan</surname><given-names>A</given-names></name><name><surname>Zafar</surname><given-names>SN</given-names></name></person-group>
<year>2008</year>
<article-title>Pierre Robin sequence with unilateral anophthalmia and lower limb oligodactyly: an unusual presentation of ophthalmoacromelic syndrome?</article-title>
<source>Clin Dysmorphol</source>
<volume>17</volume>
<fpage>187</fpage>
<lpage>188</lpage>
<pub-id pub-id-type="pmid">18541965</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-LeMerrer1">
        <label>20</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Le Merrer</surname><given-names>M</given-names></name><name><surname>Nessmann</surname><given-names>C</given-names></name><name><surname>Briard</surname><given-names>ML</given-names></name><name><surname>Maroteaux</surname><given-names>P</given-names></name></person-group>
<year>1988</year>
<article-title>Ophthalmo-acromelic syndrome.</article-title>
<source>Ann Genet</source>
<volume>31</volume>
<fpage>226</fpage>
<lpage>229</lpage>
<pub-id pub-id-type="pmid">3146242</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Megarbane1">
        <label>21</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Megarbane</surname><given-names>A</given-names></name><name><surname>Souraty</surname><given-names>N</given-names></name><name><surname>Tamraz</surname><given-names>J</given-names></name></person-group>
<year>1998</year>
<article-title>Ophthalmo-acromelic syndrome (Waardenburg) with split hand and polydactyly.</article-title>
<source>Genet Couns</source>
<volume>9</volume>
<fpage>195</fpage>
<lpage>199</lpage>
<pub-id pub-id-type="pmid">9777341</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Pallotta1">
        <label>22</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pallotta</surname><given-names>R</given-names></name><name><surname>Dallapiccola</surname><given-names>B</given-names></name></person-group>
<year>1984</year>
<article-title>A syndrome with true anophthalmia, hand-foot defects and mental retardation.</article-title>
<source>Ophthalmic Paediatr Genet</source>
<volume>4</volume>
<fpage>19</fpage>
<lpage>23</lpage>
<pub-id pub-id-type="pmid">6544388</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Quarrell1">
        <label>23</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Quarrell</surname><given-names>OW</given-names></name></person-group>
<year>1995</year>
<article-title>Ophthalmo acromelic syndrome.</article-title>
<source>Clin Dysmorphol</source>
<volume>4</volume>
<fpage>272</fpage>
<lpage>273</lpage>
<pub-id pub-id-type="pmid">7551167</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-RichieriCosta1">
        <label>24</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Richieri-Costa</surname><given-names>A</given-names></name><name><surname>Gollop</surname><given-names>TR</given-names></name><name><surname>Otto</surname><given-names>PG</given-names></name></person-group>
<year>1983</year>
<article-title>Brief clinical report: autosomal recessive anophthalmia with multiple congenital abnormalitiesâtype Waardenburg.</article-title>
<source>Am J Med Genet</source>
<volume>14</volume>
<fpage>607</fpage>
<lpage>615</lpage>
<pub-id pub-id-type="pmid">6846395</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Sayli1">
        <label>25</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sayli</surname><given-names>BS</given-names></name><name><surname>Akarsu</surname><given-names>AN</given-names></name><name><surname>Altan</surname><given-names>S</given-names></name></person-group>
<year>1995</year>
<article-title>Anophthalmos-syndactyly (Waardenburg) syndrome without oligodactyly of toes.</article-title>
<source>Am J Med Genet</source>
<volume>58</volume>
<fpage>18</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="pmid">7573150</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Suyugul1">
        <label>26</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Suyugul</surname><given-names>Z</given-names></name><name><surname>Seven</surname><given-names>M</given-names></name><name><surname>Hacihanefioglu</surname><given-names>S</given-names></name><name><surname>Kartal</surname><given-names>A</given-names></name><name><surname>Suyugul</surname><given-names>N</given-names></name><etal/></person-group>
<year>1996</year>
<article-title>Anophthalmia-Waardenburg syndrome: a report of three cases.</article-title>
<source>Am J Med Genet</source>
<volume>62</volume>
<fpage>391</fpage>
<lpage>397</lpage>
<pub-id pub-id-type="pmid">8723070</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Teiber1">
        <label>27</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Teiber</surname><given-names>ML</given-names></name><name><surname>Garrido</surname><given-names>JA</given-names></name><name><surname>Barreiro</surname><given-names>CZ</given-names></name></person-group>
<year>2007</year>
<article-title>Ophthalmo-acromelic syndrome: report of a case with vertebral anomalies.</article-title>
<source>Am J Med Genet A</source>
<volume>143A</volume>
<fpage>2460</fpage>
<lpage>2462</lpage>
<pub-id pub-id-type="pmid">17726691</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Tekin1">
        <label>28</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tekin</surname><given-names>M</given-names></name><name><surname>Tutar</surname><given-names>E</given-names></name><name><surname>Arsan</surname><given-names>S</given-names></name><name><surname>Atay</surname><given-names>G</given-names></name><name><surname>Bodurtha</surname><given-names>J</given-names></name></person-group>
<year>2000</year>
<article-title>Ophthalmo-acromelic syndrome: report and review.</article-title>
<source>Am J Med Genet</source>
<volume>90</volume>
<fpage>150</fpage>
<lpage>154</lpage>
<pub-id pub-id-type="pmid">10607955</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Traboulsi1">
        <label>29</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Traboulsi</surname><given-names>EI</given-names></name><name><surname>Nasr</surname><given-names>AM</given-names></name><name><surname>Fahd</surname><given-names>SD</given-names></name><name><surname>Jabbour</surname><given-names>NM</given-names></name><name><surname>Der Kaloustian</surname><given-names>VM</given-names></name></person-group>
<year>1984</year>
<article-title>Waardenburg's recessive anophthalmia syndrome.</article-title>
<source>Ophthalmic Paediatr Genet</source>
<volume>4</volume>
<fpage>13</fpage>
<lpage>18</lpage>
<pub-id pub-id-type="pmid">6549566</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Hopkins1">
        <label>30</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hopkins</surname><given-names>DR</given-names></name><name><surname>Keles</surname><given-names>S</given-names></name><name><surname>Greenspan</surname><given-names>DS</given-names></name></person-group>
<year>2007</year>
<article-title>The bone morphogenetic protein 1/Tolloid-like metalloproteinases.</article-title>
<source>Matrix Biol</source>
<volume>26</volume>
<fpage>508</fpage>
<lpage>523</lpage>
<pub-id pub-id-type="pmid">17560775</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Sieber1">
        <label>31</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sieber</surname><given-names>C</given-names></name><name><surname>Kopf</surname><given-names>J</given-names></name><name><surname>Hiepen</surname><given-names>C</given-names></name><name><surname>Knaus</surname><given-names>P</given-names></name></person-group>
<year>2009</year>
<article-title>Recent advances in BMP receptor signaling.</article-title>
<source>Cytokine Growth Factor Rev</source>
<volume>20</volume>
<fpage>343</fpage>
<lpage>355</lpage>
<pub-id pub-id-type="pmid">19897402</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Miyazono1">
        <label>32</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Miyazono</surname><given-names>K</given-names></name><name><surname>Kamiya</surname><given-names>Y</given-names></name><name><surname>Morikawa</surname><given-names>M</given-names></name></person-group>
<year>2010</year>
<article-title>Bone morphogenetic protein receptors and signal transduction.</article-title>
<source>J Biochem</source>
<volume>147</volume>
<fpage>35</fpage>
<lpage>51</lpage>
<pub-id pub-id-type="pmid">19762341</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Hu1">
        <label>33</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hu</surname><given-names>MC</given-names></name><name><surname>Wasserman</surname><given-names>D</given-names></name><name><surname>Hartwig</surname><given-names>S</given-names></name><name><surname>Rosenblum</surname><given-names>ND</given-names></name></person-group>
<year>2004</year>
<article-title>p38MAPK acts in the BMP7-dependent stimulatory pathway during epithelial cell morphogenesis and is regulated by Smad1.</article-title>
<source>J Biol Chem</source>
<volume>279</volume>
<fpage>12051</fpage>
<lpage>12059</lpage>
<pub-id pub-id-type="pmid">14718543</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-DeRobertis1">
        <label>34</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>De Robertis</surname><given-names>EM</given-names></name></person-group>
<year>2006</year>
<article-title>Spemann's organizer and self-regulation in amphibian embryos.</article-title>
<source>Nat Rev Mol Cell Biol</source>
<volume>7</volume>
<fpage>296</fpage>
<lpage>302</lpage>
<pub-id pub-id-type="pmid">16482093</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Wills1">
        <label>35</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wills</surname><given-names>A</given-names></name><name><surname>Harland</surname><given-names>RM</given-names></name><name><surname>Khokha</surname><given-names>MK</given-names></name></person-group>
<year>2006</year>
<article-title>Twisted gastrulation is required for forebrain specification and cooperates with Chordin to inhibit BMP signaling during X. tropicalis gastrulation.</article-title>
<source>Dev Biol</source>
<volume>289</volume>
<fpage>166</fpage>
<lpage>178</lpage>
<pub-id pub-id-type="pmid">16321373</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Ambrosio1">
        <label>36</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ambrosio</surname><given-names>AL</given-names></name><name><surname>Taelman</surname><given-names>VF</given-names></name><name><surname>Lee</surname><given-names>HX</given-names></name><name><surname>Metzinger</surname><given-names>CA</given-names></name><name><surname>Coffinier</surname><given-names>C</given-names></name><etal/></person-group>
<year>2008</year>
<article-title>Crossveinless-2 Is a BMP feedback inhibitor that binds Chordin/BMP to regulate Xenopus embryonic patterning.</article-title>
<source>Dev Cell</source>
<volume>15</volume>
<fpage>248</fpage>
<lpage>260</lpage>
<pub-id pub-id-type="pmid">18694564</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Dale1">
        <label>37</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dale</surname><given-names>L</given-names></name><name><surname>Evans</surname><given-names>W</given-names></name><name><surname>Goodman</surname><given-names>SA</given-names></name></person-group>
<year>2002</year>
<article-title>Xolloid-related: a novel BMP1/Tolloid-related metalloprotease is expressed during early Xenopus development.</article-title>
<source>Mech Dev</source>
<volume>119</volume>
<fpage>177</fpage>
<lpage>190</lpage>
<pub-id pub-id-type="pmid">12464431</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Yan1">
        <label>38</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yan</surname><given-names>X</given-names></name><name><surname>Lin</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>Human BAMBI cooperates with Smad7 to inhibit transforming growth factor-beta signaling.</article-title>
<source>J Biol Chem</source>
<volume>284</volume>
<fpage>30097</fpage>
<lpage>30104</lpage>
<pub-id pub-id-type="pmid">19758997</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Vannahme1">
        <label>39</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vannahme</surname><given-names>C</given-names></name><name><surname>Smyth</surname><given-names>N</given-names></name><name><surname>Miosge</surname><given-names>N</given-names></name><name><surname>Gosling</surname><given-names>S</given-names></name><name><surname>Frie</surname><given-names>C</given-names></name><etal/></person-group>
<year>2002</year>
<article-title>Characterization of SMOC-1, a novel modular calcium-binding protein in basement membranes.</article-title>
<source>J Biol Chem</source>
<volume>277</volume>
<fpage>37977</fpage>
<lpage>37986</lpage>
<pub-id pub-id-type="pmid">12130637</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Vannahme2">
        <label>40</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vannahme</surname><given-names>C</given-names></name><name><surname>Gosling</surname><given-names>S</given-names></name><name><surname>Paulsson</surname><given-names>M</given-names></name><name><surname>Maurer</surname><given-names>P</given-names></name><name><surname>Hartmann</surname><given-names>U</given-names></name></person-group>
<year>2003</year>
<article-title>Characterization of SMOC-2, a modular extracellular calcium-binding protein.</article-title>
<source>Biochem J</source>
<volume>373</volume>
<fpage>805</fpage>
<lpage>814</lpage>
<pub-id pub-id-type="pmid">12741954</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Novinec1">
        <label>41</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Novinec</surname><given-names>M</given-names></name><name><surname>Kordis</surname><given-names>D</given-names></name><name><surname>Turk</surname><given-names>V</given-names></name><name><surname>Lenarcic</surname><given-names>B</given-names></name></person-group>
<year>2006</year>
<article-title>Diversity and evolution of the thyroglobulin type-1 domain superfamily.</article-title>
<source>Mol Biol Evol</source>
<volume>23</volume>
<fpage>744</fpage>
<lpage>755</lpage>
<pub-id pub-id-type="pmid">16368776</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Thomas1">
        <label>42</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Thomas</surname><given-names>JT</given-names></name><name><surname>Canelos</surname><given-names>P</given-names></name><name><surname>Luyten</surname><given-names>FP</given-names></name><name><surname>Moos</surname><given-names>MJ</given-names></name></person-group>
<year>2009</year>
<article-title>Xenopus SMOC-1 Inhibits bone morphogenetic protein signaling downstream of receptor binding and is essential for postgastrulation development in Xenopus.</article-title>
<source>J Biol Chem</source>
<volume>284</volume>
<fpage>18994</fpage>
<lpage>19005</lpage>
<pub-id pub-id-type="pmid">19414592</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Friedel1">
        <label>43</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Friedel</surname><given-names>RH</given-names></name><name><surname>Seisenberger</surname><given-names>C</given-names></name><name><surname>Kaloff</surname><given-names>C</given-names></name><name><surname>Wurst</surname><given-names>W</given-names></name></person-group>
<year>2007</year>
<article-title>EUCOMMâthe European conditional mouse mutagenesis program.</article-title>
<source>Brief Funct Genomic Proteomic</source>
<volume>6</volume>
<fpage>180</fpage>
<lpage>185</lpage>
<pub-id pub-id-type="pmid">17967808</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Hitzel1">
        <label>44</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hitzel</surname><given-names>C</given-names></name><name><surname>Kanzler</surname><given-names>H</given-names></name><name><surname>Konig</surname><given-names>A</given-names></name><name><surname>Kummer</surname><given-names>MP</given-names></name><name><surname>Brix</surname><given-names>K</given-names></name><etal/></person-group>
<year>2000</year>
<article-title>Thyroglobulin type-I-like domains in invariant chain fusion proteins mediate resistance to cathepsin L digestion.</article-title>
<source>FEBS Lett</source>
<volume>485</volume>
<fpage>67</fpage>
<lpage>70</lpage>
<pub-id pub-id-type="pmid">11086167</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Pungercic1">
        <label>45</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pungercic</surname><given-names>G</given-names></name><name><surname>Dolenc</surname><given-names>I</given-names></name><name><surname>Dolinar</surname><given-names>M</given-names></name><name><surname>Bevec</surname><given-names>T</given-names></name><name><surname>Jenko</surname><given-names>S</given-names></name><etal/></person-group>
<year>2002</year>
<article-title>Individual recombinant thyroglobulin type-1 domains are substrates for lysosomal cysteine proteinases.</article-title>
<source>Biol Chem</source>
<volume>383</volume>
<fpage>1809</fpage>
<lpage>1812</lpage>
<pub-id pub-id-type="pmid">12530546</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Lu1">
        <label>46</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Qian</surname><given-names>J</given-names></name><name><surname>Keppler</surname><given-names>D</given-names></name><name><surname>Cardoso</surname><given-names>WV</given-names></name></person-group>
<year>2007</year>
<article-title>Cathespin H is an Fgf10 target involved in Bmp4 degradation during lung branching morphogenesis.</article-title>
<source>J Biol Chem</source>
<volume>282</volume>
<fpage>22176</fpage>
<lpage>22184</lpage>
<pub-id pub-id-type="pmid">17500053</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Stopper1">
        <label>47</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stopper</surname><given-names>GF</given-names></name><name><surname>Wagner</surname><given-names>GP</given-names></name></person-group>
<year>2007</year>
<article-title>Inhibition of Sonic hedgehog signaling leads to posterior digit loss in Ambystoma mexicanum: parallels to natural digit reduction in urodeles.</article-title>
<source>Dev Dyn</source>
<volume>236</volume>
<fpage>321</fpage>
<lpage>331</lpage>
<pub-id pub-id-type="pmid">17117438</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Towers1">
        <label>48</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Towers</surname><given-names>M</given-names></name><name><surname>Mahood</surname><given-names>R</given-names></name><name><surname>Yin</surname><given-names>Y</given-names></name><name><surname>Tickle</surname><given-names>C</given-names></name></person-group>
<year>2008</year>
<article-title>Integration of growth and specification in chick wing digit-patterning.</article-title>
<source>Nature</source>
<volume>452</volume>
<fpage>882</fpage>
<lpage>886</lpage>
<pub-id pub-id-type="pmid">18354396</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Katagiri1">
        <label>49</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Katagiri</surname><given-names>T</given-names></name><name><surname>Boorla</surname><given-names>S</given-names></name><name><surname>Frendo</surname><given-names>JL</given-names></name><name><surname>Hogan</surname><given-names>BL</given-names></name><name><surname>Karsenty</surname><given-names>G</given-names></name></person-group>
<year>1998</year>
<article-title>Skeletal abnormalities in doubly heterozygous Bmp4 and Bmp7 mice.</article-title>
<source>Dev Genet</source>
<volume>22</volume>
<fpage>340</fpage>
<lpage>348</lpage>
<pub-id pub-id-type="pmid">9664686</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Robert1">
        <label>50</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Robert</surname><given-names>B</given-names></name></person-group>
<year>2007</year>
<article-title>Bone morphogenetic protein signaling in limb outgrowth and patterning.</article-title>
<source>Dev Growth Differ</source>
<volume>49</volume>
<fpage>455</fpage>
<lpage>468</lpage>
<pub-id pub-id-type="pmid">17661740</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Ashe1">
        <label>51</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ashe</surname><given-names>HL</given-names></name><name><surname>Briscoe</surname><given-names>J</given-names></name></person-group>
<year>2006</year>
<article-title>The interpretation of morphogen gradients.</article-title>
<source>Development</source>
<volume>133</volume>
<fpage>385</fpage>
<lpage>394</lpage>
<pub-id pub-id-type="pmid">16410409</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Schwank1">
        <label>52</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schwank</surname><given-names>G</given-names></name><name><surname>Basler</surname><given-names>K</given-names></name></person-group>
<year>2010</year>
<article-title>Regulation of organ growth by morphogen gradients.</article-title>
<source>Cold Spring Harb Perspect Biol</source>
<volume>2</volume>
<fpage>a001669</fpage>
<pub-id pub-id-type="pmid">20182606</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Affolter1">
        <label>53</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Affolter</surname><given-names>M</given-names></name><name><surname>Basler</surname><given-names>K</given-names></name></person-group>
<year>2007</year>
<article-title>The Decapentaplegic morphogen gradient: from pattern formation to growth regulation.</article-title>
<source>Nat Rev Genet</source>
<volume>8</volume>
<fpage>663</fpage>
<lpage>674</lpage>
<pub-id pub-id-type="pmid">17703237</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Vuilleumier1">
        <label>54</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vuilleumier</surname><given-names>R</given-names></name><name><surname>Springhorn</surname><given-names>A</given-names></name><name><surname>Patterson</surname><given-names>L</given-names></name><name><surname>Koidl</surname><given-names>S</given-names></name><name><surname>Hammerschmidt</surname><given-names>M</given-names></name><etal/></person-group>
<year>2010</year>
<article-title>Control of Dpp morphogen signalling by a secreted feedback regulator.</article-title>
<source>Nat Cell Biol</source>
<volume>12</volume>
<fpage>611</fpage>
<lpage>617</lpage>
<pub-id pub-id-type="pmid">20453847</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Rogulja1">
        <label>55</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rogulja</surname><given-names>D</given-names></name><name><surname>Irvine</surname><given-names>KD</given-names></name></person-group>
<year>2005</year>
<article-title>Regulation of cell proliferation by a morphogen gradient.</article-title>
<source>Cell</source>
<volume>123</volume>
<fpage>449</fpage>
<lpage>461</lpage>
<pub-id pub-id-type="pmid">16269336</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Maatouk1">
        <label>56</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Maatouk</surname><given-names>DM</given-names></name><name><surname>Choi</surname><given-names>KS</given-names></name><name><surname>Bouldin</surname><given-names>CM</given-names></name><name><surname>Harfe</surname><given-names>BD</given-names></name></person-group>
<year>2009</year>
<article-title>In the limb AER Bmp2 and Bmp4 are required for dorsal-ventral patterning and interdigital cell death but not limb outgrowth.</article-title>
<source>Dev Biol</source>
<volume>327</volume>
<fpage>516</fpage>
<lpage>523</lpage>
<pub-id pub-id-type="pmid">19210962</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-PajniUnderwood1">
        <label>57</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pajni-Underwood</surname><given-names>S</given-names></name><name><surname>Wilson</surname><given-names>CP</given-names></name><name><surname>Elder</surname><given-names>C</given-names></name><name><surname>Mishina</surname><given-names>Y</given-names></name><name><surname>Lewandoski</surname><given-names>M</given-names></name></person-group>
<year>2007</year>
<article-title>BMP signals control limb bud interdigital programmed cell death by regulating FGF signaling.</article-title>
<source>Development</source>
<volume>134</volume>
<fpage>2359</fpage>
<lpage>2368</lpage>
<pub-id pub-id-type="pmid">17537800</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Chang1">
        <label>58</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chang</surname><given-names>B</given-names></name><name><surname>Smith</surname><given-names>RS</given-names></name><name><surname>Peters</surname><given-names>M</given-names></name><name><surname>Savinova</surname><given-names>OV</given-names></name><name><surname>Hawes</surname><given-names>NL</given-names></name><etal/></person-group>
<year>2001</year>
<article-title>Haploinsufficient Bmp4 ocular phenotypes include anterior segment dysgenesis with elevated intraocular pressure.</article-title>
<source>BMC Genet</source>
<volume>2</volume>
<fpage>18</fpage>
<pub-id pub-id-type="pmid">11722794</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Furuta1">
        <label>59</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Furuta</surname><given-names>Y</given-names></name><name><surname>Hogan</surname><given-names>BL</given-names></name></person-group>
<year>1998</year>
<article-title>BMP4 is essential for lens induction in the mouse embryo.</article-title>
<source>Genes Dev</source>
<volume>12</volume>
<fpage>3764</fpage>
<lpage>3775</lpage>
<pub-id pub-id-type="pmid">9851982</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Suzuki1">
        <label>60</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>S</given-names></name><name><surname>Marazita</surname><given-names>ML</given-names></name><name><surname>Cooper</surname><given-names>ME</given-names></name><name><surname>Miwa</surname><given-names>N</given-names></name><name><surname>Hing</surname><given-names>A</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>Mutations in BMP4 are associated with subepithelial, microform, and overt cleft lip.</article-title>
<source>Am J Hum Genet</source>
<volume>84</volume>
<fpage>406</fpage>
<lpage>411</lpage>
<pub-id pub-id-type="pmid">19249007</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Okada1">
        <label>61</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Okada</surname><given-names>I</given-names></name><name><surname>Hamanoue</surname><given-names>H</given-names></name><name><surname>Terada</surname><given-names>K</given-names></name><name><surname>Tohma</surname><given-names>T</given-names></name><name><surname>Megarbane</surname><given-names>A</given-names></name><etal/></person-group>
<year>2011</year>
<article-title>SMOC1 is essential for ocular and limb development in humans and mice.</article-title>
<source>Am J Hum Genet</source>
<volume>88</volume>
<fpage>30</fpage>
<lpage>41</lpage>
<pub-id pub-id-type="pmid">21194678</pub-id></element-citation>
      </ref>
      <ref id="pgen.1002114-Harewood1">
        <label>62</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Harewood</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Keeling</surname><given-names>J</given-names></name><name><surname>Howatson</surname><given-names>A</given-names></name><name><surname>Whiteford</surname><given-names>M</given-names></name><etal/></person-group>
<year>2010</year>
<article-title>Bilateral renal agenesis/hypoplasia/dysplasia (BRAHD): postmortem analysis of 45 cases with breakpoint mapping of two de novo translocations.</article-title>
<source>PLoS ONE</source>
<volume>5</volume>
<fpage>e12375</fpage>
<comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0012375">10.1371/journal.pone.0012375</ext-link></comment>
<pub-id pub-id-type="pmid">20811621</pub-id></element-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>